Inhibition	O
of	O
T	O
cell	O
signaling	O
by	O
mitogen-activated	B-protein
protein	I-protein
kinase-targeted	I-protein
hematopoietic	I-protein
tyrosine	I-protein
phosphatase	I-protein
(	O
HePTP	B-protein
)	O
.	O

Activation	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
to	O
produce	O
cytokines	B-protein
is	O
regulated	O
by	O
the	O
counterbalance	O
of	O
protein-tyrosine	B-protein
kinases	I-protein
and	O
protein-tyrosine	O
phosphatases	O
,	O
many	O
of	O
which	O
have	O
a	O
high	O
degree	O
of	O
substrate	O
specificity	O
because	O
of	O
physical	O
association	O
with	O
their	O
targets	O
.	O

Overexpression	O
of	O
hematopoietic	B-protein
protein-tyrosine	I-protein
phosphatase	I-protein
(	O
HePTP	B-protein
)	O
results	O
in	O
suppression	O
of	O
T	O
lymphocyte	O
activation	O
as	O
measured	O
by	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
-induced	O
activation	O
of	O
transcription	B-protein
factors	I-protein
binding	O
to	O
the	O
5	B-DNA
'	I-DNA
promoter	I-DNA
of	O
the	O
interleukin-2	B-DNA
gene	I-DNA
.	O

Efforts	O
to	O
pinpoint	O
the	O
exact	O
site	O
of	O
action	O
and	O
specificity	O
of	O
HePTP	B-protein
in	O
the	O
signaling	O
cascade	O
revealed	O
that	O
HePTP	B-protein
acts	O
directly	O
on	O
the	O
mitogen-activated	B-protein
protein	I-protein
(	I-protein
MAP	I-protein
)	I-protein
kinases	I-protein
Erk1	B-protein
and	I-protein
2	I-protein
and	O
consequently	O
reduces	O
the	O
magnitude	O
and	O
duration	O
of	O
their	O
catalytic	O
activation	O
in	O
intact	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
,	O
HePTP	B-protein
had	O
no	O
effects	O
on	O
N-terminal	B-protein
c-Jun	I-protein
kinase	I-protein
or	O
on	O
events	O
upstream	O
of	O
the	O
MAP	O
kinases	O
.	O

The	O
specificity	O
of	O
HePTP	B-protein
correlated	O
with	O
its	O
physical	O
association	O
through	O
its	O
noncatalytic	O
N	B-protein
terminus	I-protein
with	O
Erk	B-protein
and	O
another	O
MAP	B-protein
kinase	I-protein
,	O
p38	B-protein
,	O
but	O
not	O
Jnk	B-protein
or	O
other	O
proteins	O
.	O

We	O
propose	O
that	O
HePTP	B-protein
plays	O
a	O
negative	O
role	O
in	O
antigen	O
receptor	O
signaling	O
by	O
specifically	O
regulating	O
MAP	B-protein
kinases	I-protein
in	O
the	O
cytosol	O
and	O
at	O
early	O
time	O
points	O
of	O
T	O
cell	O
activation	O
before	O
the	O
activation-induced	O
expression	O
of	O
nuclear	B-protein
dual-specific	I-protein
MAP	I-protein
kinase	I-protein
phosphatases	I-protein
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

17	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
23	NULL
,	NULL
pp	NULL
.	NULL

11693-11700	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Inhibition	NULL
of	NULL
T	NULL
Cell	NULL
Signaling	NULL
by	NULL
Mitogen-activated	NULL
Protein	NULL
Kinase-targeted	NULL
Hematopoietic	NULL
Tyrosine	NULL
Phosphatase	NULL
(	NULL
HePTP	NULL
)	NULL
*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
November	NULL
23	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
3	NULL
,	NULL
1999	NULL
)	NULL
Manju	NULL
Saxenat	NULL
,	NULL
Scott	NULL
Williamst	NULL
,	NULL
Johannes	NULL
Brockdorff§	NULL
,	NULL
Jennifer	NULL
Gilman	NULL
,	NULL
and	NULL
Tomas	NULL
Mustelin	NULL
$	NULL
]	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
La	NULL
Jolla	NULL
Institute	NULL
for	NULL
Allergy	NULL
and	NULL
Immunology	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
California	NULL
92121	NULL
Activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
to	NULL
produce	NULL
cytokines	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
counterbalance	NULL
of	NULL
protein-tyrosine	NULL
kinases	NULL
and	NULL
protein-tyrosine	NULL
phosphatases	NULL
,	NULL
many	NULL
of	NULL
which	NULL
have	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
substrate	NULL
specificity	NULL
because	NULL
of	NULL
physical	NULL
association	NULL
with	NULL
their	NULL
targets	NULL
.	NULL

Overexpression	NULL
of	NULL
hematopoietic	NULL
protein-tyrosine	NULL
phosphatase	NULL
(	NULL
HePTP	NULL
)	NULL
results	NULL
in	NULL
suppression	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
as	NULL
measured	NULL
by	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-induced	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
5	NULL
promoter	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Efforts	NULL
to	NULL
pinpoint	NULL
the	NULL
exact	NULL
site	NULL
of	NULL
action	NULL
and	NULL
specificity	NULL
of	NULL
HePTP	NULL
in	NULL
the	NULL
signaling	NULL
cascade	NULL
revealed	NULL
that	NULL
HePTP	NULL
acts	NULL
directly	NULL
on	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinases	NULL
Erkl	NULL
and	NULL
2	NULL
and	NULL
consequently	NULL
reduces	NULL
the	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
their	NULL
catalytic	NULL
activation	NULL
in	NULL
intact	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
HePTP	NULL
had	NULL
no	NULL
effects	NULL
on	NULL
N-terminal	NULL
c-Jun	NULL
kinase	NULL
or	NULL
on	NULL
events	NULL
upstream	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
HePTP	NULL
correlated	NULL
with	NULL
its	NULL
physical	NULL
association	NULL
through	NULL
its	NULL
noncatalytic	NULL
N	NULL
terminus	NULL
with	NULL
Erk	NULL
and	NULL
another	NULL
MAP	NULL
kinase	NULL
,	NULL
p38	NULL
,	NULL
but	NULL
not	NULL
Jnk	NULL
or	NULL
other	NULL
proteins	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
HePTP	NULL
plays	NULL
a	NULL
negative	NULL
role	NULL
in	NULL
antigen	NULL
receptor	NULL
signaling	NULL
by	NULL
specifically	NULL
regulating	NULL
MAP	NULL
kinases	NULL
in	NULL
the	NULL
cytosol	NULL
and	NULL
at	NULL
early	NULL
time	NULL
points	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
before	NULL
the	NULL
activation-induced	NULL
expression	NULL
of	NULL
nuclear	NULL
dual-specific	NULL
MAP	NULL
kinase	NULL
phosphatases	NULL
.	NULL

Phosphorylation	NULL
of	NULL
proteins	NULL
on	NULL
tyrosyl	NULL
residues	NULL
is	NULL
an	NULL
important	NULL
mechanism	NULL
for	NULL
many	NULL
signal	NULL
transduction	NULL
pathways	NULL
controlling	NULL
cell	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
development	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
)	NULL
content	NULL
of	NULL
cellular	NULL
proteins	NULL
is	NULL
the	NULL
net	NULL
result	NULL
of	NULL
the	NULL
opposing	NULL
effects	NULL
of	NULL
protein-tyrosine	NULL
kinases	NULL
and	NULL
protein-tyrosine	NULL
phosphatases	NULL
(	NULL
PTPases	NULL
)	NULL
,	NULL
most	NULL
investigators	NULL
have	NULL
concentrated	NULL
on	NULL
the	NULL
protein-tyrosine	NULL
kinases	NULL
,	NULL
and	NULL
considerably	NULL
less	NULL
is	NULL
currently	NULL
known	NULL
about	NULL
the	NULL
PTPases	NULL
.	NULL

The	NULL
hematopoietic	NULL
protein-tyrosine	NULL
phosphatase	NULL
(	NULL
HePTP	NULL
)	NULL
was	NULL
cloned	NULL
from	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Alfred	NULL
Benzon	NULL
Foundation	NULL
(	NULL
to	NULL
J	NULL
.	NULL

B	NULL
.	NULL
)	NULL

and	NULL
Grants	NULL
GM48960	NULL
,	NULL
AI85603	NULL
,	NULL
Al41481	NULL
,	NULL
and	NULL
Al40552	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
T.	NULL
M.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.9.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
Current	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Signal	NULL
Transduction	NULL
,	NULL
Sidney	NULL
Kimmel	NULL
Cancer	NULL
Center	NULL
,	NULL
10835	NULL
Altman	NULL
Row	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92121	NULL
.	NULL

§	NULL
Current	NULL
address	NULL
:	NULL
Institute	NULL
of	NULL
Medical	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
2200	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
.	NULL

4	NULL
]	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Laboratory	NULL
of	NULL
Signal	NULL
Transduction	NULL
,	NULL
Sidney	NULL
Kimmel	NULL
Cancer	NULL
Center	NULL
,	NULL
10885	NULL
Altman	NULL
Row	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92121	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
619-450-5990	NULL
(	NULL
ext	NULL
.	NULL

830	NULL
)	NULL
;	NULL
E-mail	NULL
:	NULL
tmustelin	NULL
@	NULL
skec.org	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PTPase	NULL
,	NULL
protein-tyrosine	NULL
phosphatase	NULL
;	NULL
HePTP	NULL
,	NULL
hematopoietic	NULL
protein-tyrosine	NULL
phosphatase	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
TPCK	NULL
,	NULL
L-l-tosyl-amido-2-phenylethyl	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
MBP	NULL
,	NULL
myelin	NULL
basic	NULL
protein	NULL
;	NULL
HA	NULL
,	NULL
hemagglutinin	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
expressed	NULL
in	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
in	NULL
most	NULL
leukemic	NULL
cell	NULL
lines	NULL
examined	NULL
,	NULL
including	NULL
Jurkat	NULL
T	NULL
leukemia	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

HePTP	NULL
belongs	NULL
to	NULL
a	NULL
subgroup	NULL
of	NULL
PT'Pases	NULL
with	NULL
two	NULL
other	NULL
members	NULL
,	NULL
STEP	NULL
(	NULL
7	NULL
)	NULL
and	NULL
PCPTPL	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
HePTP	NULL
,	NULL
the	NULL
other	NULL
two	NULL
enzymes	NULL
are	NULL
not	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
but	NULL
mainly	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
:	NULL
STEP	NULL
mainly	NULL
in	NULL
striatum	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
PCPTP1	NULL
particularly	NULL
in	NULL
cerebellum	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Like	NULL
PCPTPI1	NULL
and	NULL
the	NULL
46-kDa	NULL
isoform	NULL
of	NULL
STEP	NULL
,	NULL
HePTP	NULL
consists	NULL
of	NULL
a	NULL
single	NULL
PTPase	NULL
domain	NULL
that	NULL
occupies	NULL
the	NULL
C-terminal	NULL
3/4	NULL
of	NULL
the	NULL
enzyme	NULL
and	NULL
is	NULL
preceded	NULL
by	NULL
an	NULL
~80-amino	NULL
acid	NULL
noncatalytic	NULL
N	NULL
terminus	NULL
.	NULL

As	NULL
might	NULL
be	NULL
expected	NULL
from	NULL
the	NULL
lack	NULL
of	NULL
putative	NULL
transmembrane	NULL
sequences	NULL
or	NULL
other	NULL
recognizable	NULL
targeting	NULL
motifs	NULL
,	NULL
immunofluo-rescence	NULL
microscopy	NULL
indicates	NULL
that	NULL
HePTP	NULL
is	NULL
located	NULL
exclusively	NULL
in	NULL
the	NULL
cytosol	NULL
in	NULL
RBL	NULL
mast	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

?	NULL

The	NULL
biological	NULL
function	NULL
of	NULL
HePTP	NULL
has	NULL
remained	NULL
elusive	NULL
.	NULL

A	NULL
potential	NULL
role	NULL
in	NULL
cell	NULL
proliferation	NULL
or	NULL
differentiation	NULL
was	NULL
suggested	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
HePTP	NULL
gene	NULL
is	NULL
located	NULL
at	NULL
1432.1	NULL
(	NULL
11	NULL
)	NULL
on	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
chromosome	NULL
1	NULL
,	NULL
which	NULL
is	NULL
often	NULL
found	NULL
in	NULL
extra	NULL
copies	NULL
(	NULL
trisomy	NULL
)	NULL
in	NULL
bone	NULL
marrow	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
myelodysplastic	NULL
syndrome	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
a	NULL
disease	NULL
characterized	NULL
by	NULL
reduced	NULL
hematopoiesis	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
deletions	NULL
of	NULL
1q32	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
non-Hodkin	NULL
lymphomas	NULL
and	NULL
chronic	NULL
lymphoprolif-erative	NULL
disorders	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
excess	NULL
HePTP	NULL
may	NULL
correlate	NULL
with	NULL
reduced	NULL
proliferation	NULL
(	NULL
in	NULL
myelodys-plasia	NULL
)	NULL
and	NULL
loss	NULL
of	NULL
HePTP	NULL
with	NULL
increased	NULL
cell	NULL
proliferation	NULL
and/or	NULL
survival	NULL
.	NULL

Amplification	NULL
and	NULL
overexpression	NULL
of	NULL
HePTP	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
in	NULL
a	NULL
case	NULL
of	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
11	NULL
)	NULL
.	NULL

A	NULL
connection	NULL
with	NULL
lymphoid	NULL
proliferation	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
HePTP	NULL
gene	NULL
is	NULL
transcriptionally	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
interleukin-2	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Although	NULL
mRNA	NULL
levels	NULL
increased	NULL
severalfold	NULL
upon	NULL
stimulation	NULL
of	NULL
normal	NULL
mouse	NULL
lymphocytes	NULL
with	NULL
phytohemagglutinin	NULL
,	NULL
lipopolysaccharide	NULL
,	NULL
concanavalin	NULL
A	NULL
,	NULL
or	NULL
anti-CD3	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
HePTP	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
resting	NULL
cells	NULL
,	NULL
and	NULL
its	NULL
amount	NULL
increased	NULL
only	NULL
moderately	NULL
.	NULL

Finally	NULL
,	NULL
HePTP	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
become	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
in	NULL
RBL-2H3	NULL
mast	NULL
cells	NULL
stimulated	NULL
through	NULL
their	NULL
FeeRI	NULL
(	NULL
10	NULL
)	NULL
.	NULL

We	NULL
recently	NULL
reported	NULL
that	NULL
transient	NULL
expression	NULL
of	NULL
HePTP	NULL
in	NULL
T	NULL
cells	NULL
caused	NULL
a	NULL
clear	NULL
reduction	NULL
in	NULL
antigen	NULL
receptor-induced	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
/activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
element	NULL
taken	NULL
from	NULL
the	NULL
interleukin-2	NULL
gene	NULL
promoter	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
catalytically	NULL
inactive	NULL
C27058	NULL
mutant	NULL
of	NULL
HePTP	NULL
had	NULL
no	NULL
effect	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
PTPase	NULL
activity	NULL
of	NULL
HePTP	NULL
was	NULL
required	NULL
for	NULL
inhibition	NULL
.	NULL

We	NULL
have	NULL
continued	NULL
this	NULL
work	NULL
and	NULL
have	NULL
found	NULL
that	NULL
HePTP	NULL
inhibits	NULL
NFAT/AP-1	NULL
activation	NULL
,	NULL
and	NULL
thereby	NULL
the	NULL
entire	NULL
5	NULL
'	NULL
interleukin-2	NULL
promoter	NULL
,	NULL
by	NULL
dephosphorylating	NULL
the	NULL
Erk	NULL
MAP	NULL
kinase	NULL
.	NULL

Specificity	NULL
for	NULL
this	NULL
substrate	NULL
is	NULL
the	NULL
result	NULL
of	NULL
a	NULL
physical	NULL
association	NULL
between	NULL
HePTP	NULL
and	NULL
Erk	NULL
mediated	NULL
by	NULL
the	NULL
noncatalytic	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
.	NULL

This	NULL
region	NULL
also	NULL
bound	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
but	NULL
not	NULL
the	NULL
N-terminal	NULL
c-Jun	NULL
ki-	NULL
2	NULL
M.	NULL
Saxena	NULL
,	NULL
S.	NULL
Williams	NULL
,	NULL
and	NULL
T.	NULL
Mustelin	NULL
,	NULL
unpublished	NULL
observation	NULL
.	NULL

11693	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
11694	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
to	NULL
#	NULL
z°	NULL
x	NULL
_C	NULL
&	NULL
©	NULL
R	NULL
b	NULL
.	NULL

hat	NULL
8	NULL
MAP	NULL
kinase	NULL
MAP	NULL
kinase	NULL
60	NULL
ab2	NULL
S	NULL
%	NULL
866	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
2	NULL
g	NULL
C	NULL
<	NULL
MBP	NULL
S	NULL
300	NULL
2	NULL
300	NULL
@	NULL
``	NULL
6	NULL
120-	NULL
S	NULL
g	NULL
«	NULL
(	NULL
3	NULL
Q	NULL
’	NULL
]	NULL
,	NULL
a	NULL
?	NULL

87-	NULL
O	NULL
a	NULL
.	NULL

64-	NULL
we	NULL
wae	NULL
wae	NULL
mae	NULL
[	NULL
ZL	NULL
5	NULL
E	NULL
J11x	NULL
z	NULL
m	NULL
b	NULL
_	NULL
yo	NULL
2	NULL
«	NULL
€	NULL
39-	NULL
(	NULL
*	NULL
C	NULL
200	NULL
+	NULL
3	NULL
HePTP	NULL
_	NULL
3	NULL
C3	NULL
g	NULL
100	NULL
hens	NULL
€	NULL
J	NULL
py	NULL
anti-CD3	NULL
-	NULL
+	NULL
]	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
9	NULL
T	NULL
&	NULL
C	NULL
Z	NULL
¥	NULL
8	NULL
100	NULL
$	NULL
0	NULL
+	NULL
:	NULL
«	NULL
4b	NULL
Q	NULL
“	NULL
&	NULL
K3	NULL
=	NULL
.	NULL

oe	NULL
rin	NULL
*	NULL
R	NULL
$	NULL
©	NULL
}	NULL
anti-CD3	NULL
stimulation	NULL
,	NULL
min	NULL
9°	NULL
Q3	NULL
``	NULL
g	NULL
#	NULL
a	NULL
¥	NULL
anti-CD3/28	NULL
*=	NULL
+	NULL
``	NULL
~	NULL
+=	NULL
a	NULL
=	NULL
4	NULL
~	NULL
40	NULL
o	NULL
d	NULL
.	NULL

e	NULL
.	NULL

f	NULL
.	NULL

Anti-phospho-Erk	NULL
Anti-phospho-Mek	NULL
MAP	NULL
kinase	NULL
Mi	NULL
(	NULL
K	NULL
)	NULL
M	NULL
,	NULL
(	NULL
K	NULL
)	NULL
12	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9101112	NULL
may	NULL
1-2-4845	NULL
6	NULL
7	NULL
s	NULL
o	NULL
10	NULL
1112	NULL
52	NULL
52-|	NULL
_	NULL
u	NULL
-	NULL
em	NULL
-	NULL
a	NULL
»	NULL
ms	NULL
-	NULL
W|	NULL
'	NULL
sa-	NULL
cae	NULL
’	NULL
.	NULL

<	NULL
MBP	NULL
52	NULL
52-I	NULL
39	NULL
39-	NULL
*	NULL
re	NULL
Mek	NULL
39	NULL
|-..—	NULL
--	NULL
.-.—=.__	NULL
--	NULL
|4Erk2	NULL
=	NULL
eee	NULL
OKT3	NULL
oor	NULL
anti-CD3	NULL
-	NULL
I-	NULL
I	NULL
-	NULL
1	NULL
-	NULL
I	NULL
-	NULL
I	NULL
-T	NULL
anti-CD3	NULL
-	NULL
+	NULL
-	NULL
+	NULL
¥	NULL
:	NULL
£-	NULL
%	NULL
-+	NULL
TPA	NULL
-	NULL
c.	NULL
*	NULL
on	NULL
,	NULL
Anti-HA-tag	NULL
lac—m	NULL
Antl	NULL
HA-taq	NULL
ar-	NULL
STE	NULL
g	NULL
62	NULL
es-	NULL
em	NULL
«	NULL
@	NULL
|	NULL
«	NULL
SHP2	NULL
__	NULL
,	NULL
_	NULL
air	NULL
@	NULL
«	NULL
70	NULL
kDa	NULL
30	NULL
-	NULL
aas	NULL
am	NULL
amuse	NULL
|	NULL
<	NULL
HePTP	NULL
s2-I	NULL
TCPTP	NULL
_	NULL
527	NULL
]	NULL
«	NULL
wes	NULL
»	NULL
<	NULL
=	NULL
39-	NULL
1HePTP	NULL
ag-	NULL
*=	NULL
.._	NULL
!	NULL

_	NULL
!	NULL

!	NULL

.-l	NULL
Anti-Lck	NULL
Anti-Lock	NULL
<	NULL
p62	NULL
¢	NULL
ar-	NULL
26-	NULL
517	NULL
__	NULL
_-	NULL
___	NULL
_	NULL
|	NULL
£7	NULL
ae	NULL
us	NULL
as	NULL
on	NULL
as	NULL
as	NULL
as	NULL
an	NULL
#	NULL
#	NULL
S	NULL
we	NULL
come	NULL
-	NULL
am	NULL
-	NULL
an	NULL
el	NULL
-	NULL
<	NULL
21	NULL
kDa	NULL
``	NULL
*~	NULL
52-	NULL
|_	NULL
e	NULL
s	NULL
15-	NULL
éldl	NULL
‘	NULL
lﬁld	NULL
‘	NULL
ld	NULL
‘	NULL
l-ﬁ	NULL
'	NULL
39-	NULL
T4	NULL
T	NULL
T	NULL
x5	NULL
a	NULL
x3	NULL
F	NULL
&	NULL
q	NULL
‘	NULL
”	NULL
[	NULL
@	NULL
gy	NULL
&	NULL
C	NULL
&	NULL
C	NULL
R	NULL
&	NULL
«	NULL
&	NULL
5	NULL
Fie	NULL
¢	NULL
4	NULL
#	NULL
6	NULL
$	NULL
F	NULL
<	NULL
$	NULL
*C	NULL
«	NULL
&	NULL
*y	NULL
.	NULL

y	NULL
“	NULL
4	NULL
&	NULL
4	NULL
Q	NULL
“	NULL
SS	NULL
]	NULL
,	NULL
«	NULL
(	NULL
J	NULL
KC	NULL
;	NULL
aka	NULL
Q6	NULL
QQ	NULL
at	NULL
``	NULL
K	NULL
oa	NULL
@	NULL
at	NULL
}	NULL
3	NULL
x	NULL
>	NULL
<	NULL
§	NULL
3	NULL
``	NULL
¢	NULL
V	NULL
Y	NULL
-	NULL
¥	NULL
c	NULL
?	NULL

Qg	NULL
V	NULL
V	NULL
$	NULL
x	NULL
x	NULL
G	NULL
a.	NULL
v	NULL
V	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Inhibition	NULL
of	NULL
MAP	NULL
kinase	NULL
by	NULL
HePTP	NULL
.	NULL

a	NULL
,	NULL
time	NULL
course	NULL
of	NULL
Erk2	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
0	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
@	NULL
)	NULL
of	NULL
a	NULL
co-transfected	NULL
HePTP	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
of	NULL
myc-tagged	NULL
Erk2	NULL
MAP	NULL
kinase	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
HePTP	NULL
and	NULL
treated	NULL
with	NULL
anti-CD8e	NULL
mAbs	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

After	NULL
cell	NULL
lysis	NULL
,	NULL
the	NULL
tagged	NULL
Erk2	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-Myc	NULL
mAb	NULL
(	NULL
9E10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
kinase	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
as	NULL
substrate	NULL
.	NULL

The	NULL
radioactivity	NULL
in	NULL
the	NULL
MBP	NULL
band	NULL
was	NULL
counted	NULL
in	NULL
a	NULL
B-counter	NULL
and	NULL
is	NULL
presented	NULL
as	NULL
%	NULL
of	NULL
that	NULL
in	NULL
the	NULL
0-min	NULL
sample	NULL
.	NULL

The	NULL
shown	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
S.D	NULL
.	NULL

(	NULL
error	NULL
bars	NULL
)	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Anti-Erk2	NULL
blots	NULL
showed	NULL
equal	NULL
amounts	NULL
of	NULL
the	NULL
kinase	NULL
in	NULL
each	NULL
sample	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
HePTP	NULL
was	NULL
verified	NULL
by	NULL
anti-HA	NULL
tag	NULL
immunoblotting	NULL
of	NULL
the	NULL
lysates	NULL
.	NULL

6	NULL
,	NULL
activation	NULL
of	NULL
Erk2	NULL
in	NULL
Zap-deficient	NULL
P116	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
Myc-tagged	NULL
Erk2	NULL
plus	NULL
empty	NULL
vector	NULL
,	NULL
Zap	NULL
,	NULL
Zap	NULL
plus	NULL
HePTP	NULL
,	NULL
or	NULL
Zap	NULL
plus	NULL
HePTP-C2708	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
done	NULL
as	NULL
in	NULL
a	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
shows	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
Zap	NULL
and	NULL
HePTP	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
HA-tagged	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

c	NULL
,	NULL
activation	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
entire	NULL
5	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
.	NULL

48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
anti-CD3	NULL
(	NULL
OKT3	NULL
)	NULL
and	NULL
anti-CD28	NULL
(	NULL
9.3	NULL
)	NULL
mAbs	NULL
plus	NULL
a	NULL
secondary	NULL
sheep	NULL
anti-mouse	NULL
Ig	NULL
antibody	NULL
for	NULL
8	NULL
h	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
used	NULL
for	NULL
measurement	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
,	NULL
and	NULL
the	NULL
values	NULL
shown	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
S.D	NULL
.	NULL

from	NULL
four	NULL
separate	NULL
determinations	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
transfected	NULL
PTPases	NULL
was	NULL
verified	NULL
by	NULL
immunoblotting	NULL
.	NULL

d	NULL
,	NULL
anti-phospho-Erk	NULL
immunoblot	NULL
of	NULL
lysates	NULL
of	NULL
Lek-negative	NULL
JCaM1	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
and	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
5	NULL
min	NULL
with	NULL
anti-CD8e	NULL
.	NULL

The	NULL
same	NULL
lysates	NULL
were	NULL
blotted	NULL
with	NULL
anti-Erk2	NULL
(	NULL
Lower	NULL
half	NULL
of	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
anti-HA-tag	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
anti-Lick	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

e	NULL
,	NULL
immunoblot	NULL
of	NULL
the	NULL
same	NULL
lysates	NULL
with	NULL
anti-phospho-Mek	NULL
and	NULL
anti-Mek	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
(	NULL
anti-PTyr	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
half	NULL
of	NULL
the	NULL
lower	NULL
panel	NULL
represents	NULL
a	NULL
longer	NULL
exposure	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
than	NULL
the	NULL
upper	NULL
(	NULL
to	NULL
optimize	NULL
the	NULL
visualization	NULL
of	NULL
bands	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
other	NULL
experiments	NULL
.	NULL

f	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
of	NULL
myc-tagged	NULL
Erk2	NULL
MAP	NULL
kinase	NULL
expressed	NULL
in	NULL
JCaM1	NULL
cells	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
Lek	NULL
or	NULL
Lek	NULL
plus	NULL
HePTP	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
anti-CD8e	NULL
mAbs	NULL
for	NULL
5	NULL
min	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
20	NULL
nM	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
TPA	NULL
)	NULL
(	NULL
Zanes	NULL
8	NULL
,	NULL
10	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
autoradiogram	NULL
of	NULL
the	NULL
kinase	NULL
assay	NULL
with	NULL
MBP	NULL
as	NULL
substrate	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
Erk2	NULL
in	NULL
the	NULL
precipitates	NULL
was	NULL
visualized	NULL
by	NULL
immunoblotting	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
HePTP	NULL
was	NULL
visualized	NULL
by	NULL
anti-HA	NULL
tag	NULL
immunoblotting	NULL
of	NULL
the	NULL
lysates	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
Lick	NULL
was	NULL
visualized	NULL
by	NULL
anti-Lick	NULL
blotting	NULL
(	NULL
fourth	NULL
panel	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
M	NULL
,	NULL
of	NULL
Lek	NULL
changes	NULL
upon	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
treatment	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
in	NULL
another	NULL
independent	NULL
experiment	NULL
.	NULL

nases	NULL
Jnk1	NULL
and	NULL
Jnk2	NULL
or	NULL
other	NULL
signaling	NULL
proteins	NULL
.	NULL

We	NULL
also	NULL
show	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
that	NULL
HePTP	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
Eirk	NULL
and	NULL
p38	NULL
,	NULL
and	NULL
we	NULL
identify	NULL
the	NULL
Reagents-Most	NULL
antibodies	NULL
and	NULL
plasmids	NULL
were	NULL
as	NULL
described	NULL
before	NULL
sites	NULL
of	NULL
phosphorylation	NULL
and	NULL
effects	NULL
of	NULL
phosphorylation	NULL
on	NULL
the	NULL
_	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
HePTP	NULL
fragments	NULL
AN	NULL
(	NULL
amino	NULL
acids	NULL
92-889	NULL
)	NULL
,	NULL
N	NULL
ter	NULL
(	NULL
amino	NULL
acids	NULL
association	NULL
between	NULL
HePTP	NULL
and	NULL
these	NULL
kinases	NULL
.	NULL

1-92	NULL
)	NULL
,	NULL
N1	NULL
(	NULL
amino	NULL
acids	NULL
1-40	NULL
)	NULL
,	NULL
N2	NULL
(	NULL
amino	NULL
acids	NULL
10-55	NULL
)	NULL
,	NULL
and	NULL
N3	NULL
(	NULL
amino	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
a	NULL
anti-PTyr	NULL
11695	NULL
120-	NULL
a7	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Direct	NULL
inhibition	NULL
of	NULL
Erk	NULL
by	NULL
HePTP	NULL
.	NULL

a	NULL
,	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
(	NULL
anti-PTyr	NULL
)	NULL
immu-	NULL
52-1	NULL
noblot	NULL
of	NULL
kinase-inactive	NULL
GST-Erk1	NULL
phos-	NULL
#	NULL
9	NULL
]	NULL
54	NULL
__|	NULL
Cet	NULL
em	NULL
ms	NULL
ss	NULL
<	NULL
4GST-Erk1	NULL
phorylated	NULL
by	NULL
active	NULL
Mek	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
mM	NULL
ATP	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
active	NULL
HePTP	NULL
for	NULL
the	NULL
indicated	NULL
“	NULL
IQGST-Erk	NULL
'	NULL
l	NULL
times	NULL
.	NULL

PSer	NULL
,	NULL
Ser	NULL
(	NULL
P	NULL
)	NULL
.	NULL

b	NULL
,	NULL
phosphoamino	NULL
acid	NULL
0	NULL
10	NULL
``	NULL
30	NULL
``	NULL
1°	NULL
5°	NULL
analysis	NULL
(	NULL
PAA	NULL
)	NULL
of	NULL
kinase-inactive	NULL
GST	NULL
Erk1	NULL
phosphorylated	NULL
by	NULL
Mek	NULL
in	NULL
the	NULL
pres-	NULL
d	NULL
ence	NULL
of	NULL
[	NULL
y-°°P	NULL
]	NULL
JATP	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
MAP	NULL
kinase	NULL
MAP	NULL
kinase	NULL
incubated	NULL
with	NULL
active	NULL
HePTP	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

c	NULL
,	NULL
phosphorylation	NULL
of	NULL
MBP	NULL
during	NULL
a	NULL
30-min	NULL
assay	NULL
by	NULL
10	NULL
ng	NULL
of	NULL
recombinant	NULL
Erk2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
ng	NULL
of	NULL
GST-HePTP	NULL
,	NULL
GST	NULL
,	NULL
GST-HePTP-C2708	NULL
,	NULL
or	NULL
GST-SHP2	NULL
.	NULL

d	NULL
,	NULL
similar	NULL
assay	NULL
in	NULL
the	NULL
«	NULL
<	NULL
«	NULL
Erk2	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
eus	NULL
GST-HePTP	NULL
or	NULL
controls	NULL
.	NULL

Similar	NULL
results	NULL
r	NULL
were	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
three	NULL
independ-	NULL
&	NULL
F	NULL
ent	NULL
experiments	NULL
each	NULL
.	NULL

5.10	NULL
8	NULL
d	NULL
8	NULL
&	NULL
+	NULL
a	NULL
&	NULL
acids	NULL
30-80	NULL
)	NULL
were	NULL
amplified	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
using	NULL
primers	NULL
tailed	NULL
with	NULL
NkelI	NULL
and	NULL
Nde	NULL
!	NULL

sites	NULL
and	NULL
the	NULL
HePTP	NULL
cDNA	NULL
as	NULL
a	NULL
template	NULL
.	NULL

The	NULL
resulting	NULL
fragments	NULL
were	NULL
then	NULL
subcloned	NULL
into	NULL
the	NULL
pGEX-4T-3	NULL
vector	NULL
and	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
expressed	NULL
and	NULL
purified	NULL
with	NULL
glutathione-Sepharose	NULL
using	NULL
standard	NULL
techniques	NULL
as	NULL
before	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
for	NULL
activated	NULL
Mek	NULL
(	NULL
S218D/8222D	NULL
mutated	NULL
)	NULL
in	NULL
the	NULL
pUSE	NULL
vector	NULL
and	NULL
recombinant	NULL
active	NULL
Mek	NULL
,	NULL
kinase-inactive	NULL
Erk1	NULL
,	NULL
active	NULL
Erk2	NULL
,	NULL
and	NULL
active	NULL
p38	NULL
were	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Luciferase	NULL
reporter	NULL
constructs	NULL
in	NULL
the	NULL
pGL2	NULL
promoter	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
containing	NULL
multiple	NULL
copies	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
-211	NULL
to	NULL
-192	NULL
,	NULL
8	NULL
times	NULL
)	NULL
,	NULL
Oct	NULL
(	NULL
-97	NULL
to	NULL
-64	NULL
,	NULL
7	NULL
times	NULL
)	NULL
,	NULL
or	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
T.	NULL
Kawakami	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Anti-phospho-Eirk	NULL
and	NULL
anti-phospho-Mek	NULL
were	NULL
purchased	NULL
from	NULL
Promega	NULL
and	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

Site-directed	NULL
Mutagenesis-As	NULL
described	NULL
earlier	NULL
(	NULL
6	NULL
)	NULL
for	NULL
the	NULL
catalytically	NULL
inactive	NULL
mutant	NULL
of	NULL
HePTP	NULL
(	NULL
C2708	NULL
)	NULL
,	NULL
the	NULL
872A	NULL
and	NULL
T45A	NULL
mutants	NULL
were	NULL
generated	NULL
using	NULL
the	NULL
Transformer	NULL
``	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Mutations	NULL
were	NULL
verified	NULL
by	NULL
nucleotide	NULL
sequencing	NULL
.	NULL

Cells	NULL
,	NULL
Transfections	NULL
,	NULL
and	NULL
Luciferase	NULL
Assays-Jurkat	NULL
T	NULL
leukemia	NULL
cells	NULL
and	NULL
two	NULL
variants	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
JCaM1.6	NULL
,	NULL
which	NULL
lacks	NULL
Lek	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
P116	NULL
,	NULL
which	NULL
lacks	NULL
Zap-70	NULL
(	NULL
Ref	NULL
.	NULL

18	NULL
;	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
R.	NULL
Abraham	NULL
)	NULL
,	NULL
were	NULL
kept	NULL
at	NULL
logarithmic	NULL
growth	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
total	NULL
of	NULL
5-10	NULL
ug	NULL
of	NULL
DNA	NULL
by	NULL
electroporation	NULL
at	NULL
950	NULL
micro-farads	NULL
and	NULL
240	NULL
V	NULL
as	NULL
before	NULL
.	NULL

Empty	NULL
vector	NULL
was	NULL
added	NULL
to	NULL
control	NULL
samples	NULL
to	NULL
make	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
done	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
before	NULL
(	NULL
6	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Immunoblots	NULL
,	NULL
Immunoprecipitation	NULL
,	NULL
and	NULL
in	NULL
Vitro	NULL
Kinase	NULL
Assays-Immunoprecipitation	NULL
and	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
were	NULL
done	NULL
as	NULL
before	NULL
(	NULL
6	NULL
,	NULL
20	NULL
)	NULL
.	NULL

All	NULL
immunoblots	NULL
were	NULL
developed	NULL
by	NULL
the	NULL
enhanced	NULL
chemilumines-cence	NULL
technique	NULL
(	NULL
ECL	NULL
kit	NULL
,	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Phosphoamino	NULL
Acid	NULL
Analysis	NULL
and	NULL
Tryptic	NULL
Peptide	NULL
Mapping-GST-HePTP	NULL
protein	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
the	NULL
bound	NULL
kinase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*°PJATP	NULL
was	NULL
resolved	NULL
on	NULL
10	NULL
%	NULL
SDS	NULL
gels	NULL
and	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
,	NULL
and	NULL
the	NULL
phosphorylated	NULL
band	NULL
was	NULL
excised	NULL
and	NULL
digested	NULL
with	NULL
TPCK-treated	NULL
trypsin	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
by	NULL
Luo	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
.	NULL

RESULTS	NULL
HePTP	NULL
Reduces	NULL
AP-1-dependent	NULL
Gene	NULL
Activation-A	NULL
crucial	NULL
step	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
is	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
by	NULL
T	NULL
cells	NULL
challenged	NULL
with	NULL
properly	NULL
presented	NULL
antigen	NULL
(	NULL
22	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor-induced	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
is	NULL
the	NULL
result	NULL
of	NULL
the	NULL
coordinated	NULL
action	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
including	NULL
a	NULL
trimeric	NULL
complex	NULL
consisting	NULL
of	NULL
a	NULL
NFAT	NULL
family	NULL
protein	NULL
(	NULL
25	NULL
)	NULL
and	NULL
an	NULL
AP-1	NULL
GST	NULL
GST-HePTP	NULL
O	NULL
GST	NULL
HePTP	NULL
est|	NULL
A	NULL
GST-HePTP-c2708	NULL
@	NULL
est	NULL
GST-HePTP-c2705	NULL
@	NULL
0	NULL
A	NULL
.	NULL

5	NULL
ha	NULL
w	NULL
&	NULL
g	NULL
w	NULL
8	NULL
D	NULL
d	NULL
g	NULL
g.	NULL
E	NULL
&	NULL
+	NULL
a	NULL
8	NULL
GST-SHP2	NULL
dimer	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
proteins	NULL
,	NULL
with	NULL
some	NULL
assistance	NULL
from	NULL
octamer-binding	NULL
proteins	NULL
(	NULL
Oct	NULL
)	NULL
and	NULL
NF-kB	NULL
.	NULL

Although	NULL
these	NULL
proteins	NULL
operate	NULL
in	NULL
a	NULL
synergistic	NULL
manner	NULL
,	NULL
they	NULL
can	NULL
be	NULL
measured	NULL
separately	NULL
using	NULL
their	NULL
target	NULL
DNA	NULL
elements	NULL
coupled	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

When	NULL
HePTP	NULL
was	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
together	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
5	NULL
'	NULL
interleukin-2	NULL
promoter	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
reporter	NULL
was	NULL
reduced	NULL
to	NULL
58.1	NULL
+	NULL
9.3	NULL
%	NULL
(	NULL
n	NULL
=	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
catalytically	NULL
inactive	NULL
mutant	NULL
HePTP-C2705	NULL
or	NULL
two	NULL
other	NULL
PTPases	NULL
,	NULL
SHP2	NULL
and	NULL
TCPTP	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
although	NULL
being	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
.	NULL

The	NULL
inhibition	NULL
by	NULL
HePTP	NULL
was	NULL
not	NULL
as	NULL
pronounced	NULL
as	NULL
its	NULL
effect	NULL
on	NULL
a	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
subregion	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
,	NULL
one	NULL
of	NULL
the	NULL
NFAT/AP-1	NULL
response	NULL
elements	NULL
,	NULL
which	NULL
was	NULL
inhibited	NULL
by	NULL
more	NULL
than	NULL
80	NULL
%	NULL
(	NULL
6	NULL
)	NULL
.	NULL

This	NULL
discrepancy	NULL
is	NULL
probably	NULL
explained	NULL
by	NULL
the	NULL
minimal	NULL
effects	NULL
of	NULL
HePTP	NULL
on	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
Oct	NULL
or	NULL
NF-kB	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
further	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
HePTP	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
antigen-induced	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
suggests	NULL
that	NULL
HePTP	NULL
dephosphorylates	NULL
some	NULL
signaling	NULL
molecule	NULL
in	NULL
the	NULL
pathways	NULL
that	NULL
lead	NULL
from	NULL
the	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NFAT/AP-1	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
examine	NULL
several	NULL
receptor-proximal	NULL
signaling	NULL
steps	NULL
upstream	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
complex	NULL
.	NULL

HePTP	NULL
Inhibits	NULL
Erk	NULL
but	NULL
Not	NULL
Ink-First	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
two	NULL
types	NULL
of	NULL
MAP	NULL
kinases	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
AP-1	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
Erk	NULL
and	NULL
Junk	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
epitope-tagged	NULL
Erk2	NULL
together	NULL
with	NULL
HePTP	NULL
,	NULL
HePTP-C2708	NULL
,	NULL
TCPTP	NULL
,	NULL
or	NULL
SHP2	NULL
.	NULL

After	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
the	NULL
catalytic	NULL
activity	NULL
of	NULL
the	NULL
kinases	NULL
was	NULL
meas-ured	NULL
.	NULL

These	NULL
experiments	NULL
consistently	NULL
revealed	NULL
that	NULL
the	NULL
antigen	NULL
receptor-induced	NULL
activation	NULL
of	NULL
Erk	NULL
was	NULL
significantly	NULL
reduced	NULL
by	NULL
HePTP	NULL
.	NULL

In	NULL
cells	NULL
stimulated	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
with	NULL
anti-CD3e	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
,	NULL
the	NULL
inhibition	NULL
by	NULL
HePTP	NULL
was	NULL
seen	NULL
at	NULL
all	NULL
time	NULL
points	NULL
but	NULL
most	NULL
clearly	NULL
at	NULL
2-5	NULL
min	NULL
,	NULL
coinciding	NULL
with	NULL
the	NULL
peak	NULL
of	NULL
Erk	NULL
activity	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
in	NULL
Zap-70-deficient	NULL
P116	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
co-transfected	NULL
with	NULL
Zap-70	NULL
,	NULL
except	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
both	NULL
wild-type	NULL
HePTP	NULL
and	NULL
HePTP-C2708	NULL
were	NULL
even	NULL
stronger	NULL
(	NULL
Fig	NULL
.	NULL

16	NULL
)	NULL
,	NULL
presumably	NULL
because	NULL
of	NULL
the	NULL
lower	NULL
levels	NULL
of	NULL
endogenous	NULL
HePTP	NULL
in	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

HePTP	NULL
also	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
11696	NULL
a	NULL
anti-PTyr	NULL
Mr	NULL
(	NULL
K	NULL
}	NULL
12345	NULL
6	NULL
7	NULL
8	NULL
9	NULL
120-I	NULL
87-s-	NULL
sb	NULL
26-I	NULL
21	NULL
-L	NULL
anti-Erk2	NULL
sa-s	NULL
J	NULL
decant	NULL
<	NULL
Erk2	NULL
anti-Jnk1	NULL
+	NULL
os	NULL
TS	NULL
.	NULL

39	NULL
anti-p38	NULL
is	NULL
:	NULL
f	NULL
«	NULL
»	NULL
|	NULL
<	NULL
p38	NULL
pervanadate	NULL
-	NULL
+	NULL
]	NULL
-	NULL
+	NULL
]	NULL
-	NULL
+|—m+|-®	NULL
&	NULL
$	NULL
3	NULL
$	NULL
2	NULL
}	NULL
a	NULL
#	NULL
45	NULL
“	NULL
C	NULL
(	NULL
94	NULL
?	NULL

if	NULL
é	NULL
c	NULL
}	NULL
£	NULL
C	NULL
anti-p38	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
71.4-	NULL
46.4-I	NULL
“	NULL
q	NULL
“	NULL
.-.ﬂ	NULL
‘	NULL
p38	NULL
28.3-anti-CD3	NULL
~N+I-	NULL
+	NULL
]	NULL
-	NULL
+1-	NULL
+1-£3	NULL
£53	NULL
&	NULL
«	NULL
63	NULL
$	NULL
4	NULL
#	NULL
4	NULL
ﬁts	NULL
?	NULL

I	NULL
?	NULL

“	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
b	NULL
Kinase	NULL
assay	NULL
MK	NULL
)	NULL
1	NULL
2	NULL
s	NULL
4	NULL
5s	NULL
6	NULL
7	NULL
8	NULL
120-em	NULL
=	NULL
|	NULL
<	NULL
GST-HePTP	NULL
39-26-	NULL
~	NULL
ar-	NULL
wite	NULL
u.-4MBP	NULL
120-a-	NULL
am	NULL
__	NULL
|	NULL
<	NULL
GST-HePTP	NULL
t	NULL
@	NULL
»	NULL
-	NULL
|	NULL
<	NULL
GST-ATF2	NULL
26-21-	NULL
-	NULL
.	NULL

+	NULL
-1~+	NULL
’	NULL
—\°	NULL
‘	NULL
J+	NULL
391+	NULL
£	NULL
&	NULL
&	NULL
6	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Physical	NULL
association	NULL
of	NULL
HePTP	NULL
with	NULL
Erk	NULL
and	NULL
p38	NULL
but	NULL
not	NULL
Junk	NULL
.	NULL

a	NULL
,	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
(	NULL
anti-PTyr	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
anti-Erk2	NULL
(	NULL
second	NULL
panel	NULL
)	NULL
,	NULL
anti-Jnk1	NULL
(	NULL
third	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
anti-p38	NULL
(	NULL
fourth	NULL
panel	NULL
)	NULL
immunoblot	NULL
of	NULL
material	NULL
bound	NULL
to	NULL
control	NULL
GST	NULL
,	NULL
GST-HePTP	NULL
,	NULL
GST-HePTP-C2708	NULL
,	NULL
or	NULL
GST-SHP2	NULL
in	NULL
lysates	NULL
of	NULL
untreated	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
pervanadate	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
last	NULL
lane	NULL
is	NULL
cell	NULL
lysate	NULL
.	NULL

The	NULL
same	NULL
result	NULL
has	NULL
been	NULL
obtained	NULL
in	NULL
two	NULL
other	NULL
experiments	NULL
,	NULL
and	NULL
blotting	NULL
with	NULL
anti-Jnk2	NULL
was	NULL
also	NULL
negative	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

b	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
autoradiogram	NULL
of	NULL
a	NULL
kinase	NULL
reaction	NULL
of	NULL
the	NULL
same	NULL
samples	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*°PJATP	NULL
and	NULL
MBP	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Lower	NULL
panel	NULL
,	NULL
autoradiogram	NULL
of	NULL
a	NULL
kinase	NULL
reaction	NULL
of	NULL
the	NULL
same	NULL
samples	NULL
with	NULL
GST-ATF2	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

c	NULL
,	NULL
anti-p38	NULL
immunoblot	NULL
of	NULL
immunoprecipitates	NULL
obtained	NULL
with	NULL
serum	NULL
from	NULL
a	NULL
rabbit	NULL
before	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
after	NULL
immunization	NULL
with	NULL
HePTP	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
from	NULL
another	NULL
rabbit	NULL
before	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
after	NULL
immunization	NULL
with	NULL
GST-TCPTP	NULL
(	NULL
Zanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Lane	NULL
9	NULL
is	NULL
total	NULL
cell	NULL
lysate	NULL
.	NULL

d	NULL
,	NULL
anti-Eirk	NULL
immunoblot	NULL
of	NULL
the	NULL
same	NULL
immunoprecipitates	NULL
.	NULL

Lane	NULL
I	NULL
is	NULL
total	NULL
cell	NULL
lysate	NULL
.	NULL

blocked	NULL
interleukin-2	NULL
promoter	NULL
activation	NULL
more	NULL
efficiently	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
transfected	NULL
HePTP	NULL
correlates	NULL
inversely	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
endogenous	NULL
HePTP	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
observed	NULL
inhibition	NULL
of	NULL
MAP	NULL
kinase	NULL
represents	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
HePTP	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
HePTP	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
by	NULL
reducing	NULL
the	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
Eirk	NULL
activation	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
expression	NULL
of	NULL
Erk2	NULL
plus	NULL
an	NULL
activated	NULL
mutant	NULL
(	NULL
29	NULL
)	NULL
of	NULL
Mek	NULL
,	NULL
the	NULL
upstream	NULL
activator	NULL
of	NULL
Erk	NULL
,	NULL
augmented	NULL
interleukin-2	NULL
promoter	NULL
activation	NULL
and	NULL
increased	NULL
its	NULL
sensitivity	NULL
to	NULL
HePTP	NULL
(	NULL
Fig	NULL
.	NULL

le	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
co-expression	NULL
of	NULL
activated	NULL
Mkk6	NULL
plus	NULL
p38	NULL
kinases	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
interleukin-2	NULL
reporter	NULL
or	NULL
its	NULL
inhibition	NULL
by	NULL
HePTP	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
another	NULL
gene	NULL
known	NULL
to	NULL
be	NULL
up-regulated	NULL
,	NULL
in	NULL
part	NULL
,	NULL
through	NULL
Erk-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
Elk-1	NULL
transcription	NULL
factor	NULL
(	NULL
30	NULL
)	NULL
,	NULL
c-fos	NULL
,	NULL
was	NULL
also	NULL
reduced	NULL
in	NULL
T	NULL
cells	NULL
overexpressing	NULL
HePTP	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
inactive	NULL
HePTP-C2708	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
all	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
HePTP	NULL
reduces	NULL
the	NULL
activation	NULL
of	NULL
Erk	NULL
in	NULL
vivo	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
opposite	NULL
effect	NULL
of	NULL
catalytically	NULL
inactive	NULL
HePTP-C2708	NULL
in	NULL
the	NULL
same	NULL
assays	NULL
.	NULL

HePTP	NULL
Inhibits	NULL
Endogenous	NULL
Erk	NULL
but	NULL
Not	NULL
Upstream	NULL
Events-To	NULL
ascertain	NULL
that	NULL
the	NULL
observed	NULL
inhibition	NULL
by	NULL
HePTP	NULL
was	NULL
not	NULL
limited	NULL
to	NULL
exogenous	NULL
transfected	NULL
MAP	NULL
kinase	NULL
,	NULL
we	NULL
next	NULL
utilized	NULL
the	NULL
JCaM1	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
is	NULL
unresponsive	NULL
to	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
because	NULL
of	NULL
lack	NULL
of	NULL
Leck	NULL
kinase	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
Leck	NULL
(	NULL
or	NULL
Syk	NULL
)	NULL
restores	NULL
responsiveness	NULL
(	NULL
20	NULL
)	NULL
.	NULL

JCaM1l	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Lck	NULL
together	NULL
with	NULL
HePTP	NULL
,	NULL
HePTP-C2708	NULL
,	NULL
or	NULL
control	NULL
PTPases	NULL
and	NULL
used	NULL
for	NULL
analysis	NULL
of	NULL
antigen	NULL
receptor-induced	NULL
appearance	NULL
of	NULL
activated	NULL
and	NULL
phosphorylated	NULL
MAP	NULL
kinases	NULL
by	NULL
immunoblotting	NULL
with	NULL
activa-	NULL
tion-specific	NULL
antibodies	NULL
.	NULL

Fig	NULL
.	NULL

1d	NULL
shows	NULL
that	NULL
HePTP	NULL
reduced	NULL
the	NULL
appearance	NULL
of	NULL
phospho-Erk1	NULL
and	NULL
-2	NULL
,	NULL
while	NULL
at	NULL
the	NULL
same	NULL
time	NULL
and	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
,	NULL
not	NULL
having	NULL
any	NULL
effects	NULL
on	NULL
activation	NULL
of	NULL
Mek	NULL
or	NULL
the	NULL
receptor-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
cellular	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

le	NULL
)	NULL
,	NULL
including	NULL
the	NULL
{	NULL
chain	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
and	NULL
Zap-70	NULL
(	NULL
verified	NULL
by	NULL
immunoprecipitation	NULL
)	NULL
.	NULL

Additional	NULL
immunoblots	NULL
of	NULL
the	NULL
same	NULL
samples	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
endogenous	NULL
Erk	NULL
and	NULL
Mek	NULL
,	NULL
as	NULL
well	NULL
as	NULL
transfected	NULL
Lck	NULL
and	NULL
PTPases	NULL
,	NULL
was	NULL
equal	NULL
in	NULL
all	NULL
samples	NULL
.	NULL

On	NULL
longer	NULL
expo-sures	NULL
,	NULL
it	NULL
was	NULL
also	NULL
noted	NULL
that	NULL
the	NULL
catalytically	NULL
inactive	NULL
HePTP-C2708	NULL
elevated	NULL
the	NULL
amount	NULL
of	NULL
phospho-Erk	NULL
in	NULL
the	NULL
resting	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
HePTP	NULL
readily	NULL
inhibits	NULL
endogenous	NULL
MAP	NULL
kinase	NULL
,	NULL
and	NULL
the	NULL
catalytically	NULL
inactive	NULL
HePTP-C2708	NULL
acts	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
reducing	NULL
the	NULL
action	NULL
of	NULL
endogenous	NULL
HePTP	NULL
.	NULL

HePTP	NULL
Also	NULL
Inhibits	NULL
Phorbol	NULL
Ester-induced	NULL
Erk	NULL
Activation-The	NULL
MAP	NULL
kinase	NULL
pathway	NULL
can	NULL
also	NULL
be	NULL
efficiently	NULL
activated	NULL
by	NULL
phorbol	NULL
esters	NULL
,	NULL
which	NULL
bypass	NULL
all	NULL
receptor-induced	NULL
proximal	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
by	NULL
activating	NULL
the	NULL
Raf	NULL
kinase	NULL
through	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

When	NULL
tagged	NULL
Erk2	NULL
was	NULL
expressed	NULL
in	NULL
JCaM1	NULL
cells	NULL
together	NULL
with	NULL
HePTP	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
20	NULL
nm	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
was	NULL
profoundly	NULL
inhibited	NULL
compared	NULL
with	NULL
cells	NULL
expressing	NULL
Erk2	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1f	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
cells	NULL
stimulated	NULL
by	NULL
anti-CD3	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
,	NULL
phorbol	NULL
ester-induced	NULL
MAP	NULL
kinase	NULL
activation	NULL
did	NULL
not	NULL
require	NULL
expression	NULL
of	NULL
Lick	NULL
.	NULL

Control	NULL
blots	NULL
confirmed	NULL
that	NULL
the	NULL
immunoprecipitates	NULL
contained	NULL
equal	NULL
amounts	NULL
of	NULL
Erk2	NULL
and	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
HePTP	NULL
and	NULL
Lck	NULL
were	NULL
expressed	NULL
in	NULL
the	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

If	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

Because	NULL
HePTP	NULL
is	NULL
specific	NULL
for	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
,	NULL
this	NULL
result	NULL
supports	NULL
the	NULL
conclusion	NULL
that	NULL
HePTP	NULL
does	NULL
not	NULL
block	NULL
MAP	NULL
kinase	NULL
activation	NULL
by	NULL
dephosphorylating	NULL
receptor-proximal	NULL
tyrosine	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
phosphorylation	NULL
events	NULL
.	NULL

Rather	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
a	NULL
more	NULL
direct	NULL
effect	NULL
on	NULL
Erk	NULL
.	NULL

Direct	NULL
Effect	NULL
of	NULL
HePTP	NULL
on	NULL
Erk-Having	NULL
found	NULL
that	NULL
HePTP	NULL
had	NULL
no	NULL
effects	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
Mek	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
where	NULL
Erk	NULL
phosphorylation	NULL
was	NULL
reduced	NULL
,	NULL
we	NULL
asked	NULL
if	NULL
HePTP	NULL
acts	NULL
directly	NULL
on	NULL
phospho-Eirk	NULL
.	NULL

First	NULL
,	NULL
we	NULL
phosphorylated	NULL
recombinant	NULL
kinase-inactive	NULL
Erkl	NULL
at	NULL
the	NULL
activation	NULL
loop	NULL
threonine	NULL
and	NULL
tyrosine	NULL
residues	NULL
using	NULL
active	NULL
recombinant	NULL
Mek	NULL
and	NULL
treated	NULL
the	NULL
resulting	NULL
phospho-Erk	NULL
with	NULL
recombinant	NULL
HePTP	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2a	NULL
,	NULL
the	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
content	NULL
of	NULL
Erk	NULL
decreased	NULL
detectably	NULL
within	NULL
10-30	NULL
s	NULL
and	NULL
was	NULL
very	NULL
low	NULL
by	NULL
1-5	NULL
min	NULL
.	NULL

Phosphoamino	NULL
acid	NULL
analysis	NULL
of	NULL
similarly	NULL
treated	NULL
Erk	NULL
]	NULL
phosphorylated	NULL
by	NULL
Mek	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
7-32P	NULL
]	NULL
ATP	NULL
revealed	NULL
that	NULL
HePTP	NULL
caused	NULL
a	NULL
rapid	NULL
loss	NULL
of	NULL
phosphate	NULL
from	NULL
tyrosine	NULL
without	NULL
hydrolyzing	NULL
phosphothreonine	NULL
(	NULL
Fig	NULL
.	NULL

26	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
brief	NULL
incubation	NULL
at	NULL
37°C	NULL
of	NULL
active	NULL
recombinant	NULL
Erk	NULL
with	NULL
HePTP	NULL
resulted	NULL
in	NULL
a	NULL
total	NULL
loss	NULL
of	NULL
its	NULL
kinase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2¢c	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GST	NULL
,	NULL
HePTP-C2708	NULL
,	NULL
or	NULL
SHP2	NULL
had	NULL
no	NULL
effects	NULL
.	NULL

Using	NULL
10	NULL
ng	NULL
(	NULL
150	NULL
fmol	NULL
)	NULL
of	NULL
recombinant	NULL
Erk	NULL
,	NULL
we	NULL
found	NULL
that	NULL
10	NULL
ng	NULL
(	NULL
150	NULL
fmol	NULL
,	NULL
7.5	NULL
nx	NULL
)	NULL
or	NULL
more	NULL
of	NULL
HePTP	NULL
caused	NULL
a	NULL
complete	NULL
inactivation	NULL
of	NULL
Erk	NULL
within	NULL
the	NULL
first	NULL
minute	NULL
of	NULL
the	NULL
assay	NULL
,	NULL
whereas	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ng	NULL
(	NULL
15	NULL
fmol	NULL
)	NULL
of	NULL
HePTP	NULL
had	NULL
insignificant	NULL
(	NULL
<	NULL
10	NULL
%	NULL
)	NULL
effects	NULL
even	NULL
during	NULL
a	NULL
30-min	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2d	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
HePTP	NULL
acts	NULL
on	NULL
Erk	NULL
at	NULL
a	NULL
1:1	NULL
stoichiometry	NULL
,	NULL
perhaps	NULL
by	NULL
binding	NULL
and	NULL
primarily	NULL
dephosphorylating	NULL
only	NULL
the	NULL
bound	NULL
kinase	NULL
molecules	NULL
.	NULL

Physical	NULL
Association	NULL
between	NULL
HePTP	NULL
and	NULL
MAP	NULL
Kinase-To	NULL
directly	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
HePTP	NULL
binds	NULL
Erk	NULL
,	NULL
we	NULL
used	NULL
GST	NULL
fusion	NULL
proteins	NULL
of	NULL
HePTP	NULL
,	NULL
HePTP-C2708	NULL
,	NULL
or	NULL
SHP2	NULL
and	NULL
found	NULL
that	NULL
both	NULL
HePTP	NULL
and	NULL
HePTP-C2708	NULL
readily	NULL
bound	NULL
Erk	NULL
(	NULL
Fig	NULL
.	NULL

30	NULL
)	NULL
in	NULL
lysates	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
pervanadate	NULL
(	NULL
to	NULL
maximize	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
83	NULL
)	NULL
)	NULL
.	NULL

The	NULL
precipitates	NULL
also	NULL
reacted	NULL
strongly	NULL
with	NULL
antibodies	NULL
to	NULL
another	NULL
MAP	NULL
kinase	NULL
,	NULL
p38	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
Jnk1l	NULL
nor	NULL
Jnk2	NULL
bound	NULL
,	NULL
and	NULL
control	NULL
GST	NULL
,	NULL
GST-SHP2	NULL
(	NULL
Fig	NULL
.	NULL

30	NULL
)	NULL
,	NULL
or	NULL
GST-TCPTP	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
did	NULL
not	NULL
precipitate	NULL
any	NULL
of	NULL
these	NULL
kinases	NULL
.	NULL

Immunoblotting	NULL
with	NULL
antibodies	NULL
to	NULL
the	NULL
36-38-kDa	NULL
LAT	NULL
(	NULL
34	NULL
)	NULL
or	NULL
to	NULL
other	NULL
signaling	NULL
molecules	NULL
gave	NULL
negative	NULL
results	NULL
.	NULL

The	NULL
Erk	NULL
and	NULL
p38	NULL
that	NULL
bound	NULL
active	NULL
HePTP	NULL
did	NULL
not	NULL
contain	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
and	NULL
were	NULL
catalytically	NULL
inactive	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Erk	NULL
and	NULL
p38	NULL
bound	NULL
to	NULL
inactive	NULL
HePTP-C27085	NULL
from	NULL
pervanadate-treated	NULL
cells	NULL
were	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
and	NULL
enzymatically	NULL
highly	NULL
active	NULL
against	NULL
myelin	NULL
basic	NULL
protein	NULL
or	NULL
GST-ATF2	NULL
,	NULL
a	NULL
preferred	NULL
substrate	NULL
for	NULL
p38	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

In	NULL
these	NULL
reactions	NULL
,	NULL
GST-HePTP	NULL
was	NULL
also	NULL
phosphorylated	NULL
by	NULL
the	NULL
bound	NULL
Erk	NULL
and	NULL
p38	NULL
.	NULL

HePTP	NULL
also	NULL
co-immunoprecipitated	NULL
with	NULL
p38	NULL
from	NULL
untreated	NULL
or	NULL
activated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3¢	NULL
)	NULL
.	NULL

Co-immunoprecipitation	NULL
of	NULL
HePTP	NULL
and	NULL
Erk	NULL
was	NULL
not	NULL
as	NULL
clean	NULL
because	NULL
of	NULL
nonspecific	NULL
binding	NULL
of	NULL
Erk	NULL
to	NULL
Sepharose	NULL
beads	NULL
coated	NULL
with	NULL
irrelevant	NULL
immunoglobulin	NULL
(	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
HePTP	NULL
specifically	NULL
associates	NULL
with	NULL
Erk	NULL
and	NULL
p38	NULL
MAP	NULL
kinases	NULL
.	NULL

HePTP	NULL
Also	NULL
Inhibits	NULL
Activation	NULL
of	NULL
p38	NULL
Kinase	NULL
but	NULL
Not	NULL
Activation	NULL
of	NULL
Ink-The	NULL
finding	NULL
that	NULL
HePTP	NULL
associates	NULL
with	NULL
both	NULL
Erk	NULL
and	NULL
p38	NULL
,	NULL
but	NULL
not	NULL
with	NULL
Jnk	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
study	NULL
the	NULL
direct	NULL
effects	NULL
of	NULL
HePTP	NULL
on	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
p38	NULL
in	NULL
vitro	NULL
and	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
and	NULL
Jnk	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

First	NULL
,	NULL
we	NULL
used	NULL
10	NULL
ng	NULL
of	NULL
recombinant	NULL
active	NULL
p38	NULL
kinase	NULL
,	NULL
added	NULL
100	NULL
ng	NULL
of	NULL
GST-HePTP	NULL
,	NULL
GST-HePTP-C2708	NULL
,	NULL
control	NULL
GST	NULL
,	NULL
or	NULL
GST-SHP2	NULL
,	NULL
and	NULL
incubated	NULL
the	NULL
samples	NULL
with	NULL
[	NULL
7-32P	NULL
]	NULL
ATP	NULL
for	NULL
30	NULL
min	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

40	NULL
,	NULL
active	NULL
HePTP	NULL
inhibited	NULL
p38	NULL
profoundly	NULL
,	NULL
whereas	NULL
the	NULL
inactive	NULL
C2708	NULL
mutant	NULL
,	NULL
GST	NULL
,	NULL
and	NULL
the	NULL
control	NULL
SHP2	NULL
PTPase	NULL
lacked	NULL
effects	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
co-transfected	NULL
HA-tagged	NULL
p38	NULL
or	NULL
Jnk2	NULL
with	NULL
empty	NULL
vector	NULL
,	NULL
with	NULL
HePTP	NULL
,	NULL
or	NULL
with	NULL
HePTP-C2708	NULL
.	NULL

Two	NULL
days	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
mAbs	NULL
(	NULL
as	NULL
neither	NULL
mAb	NULL
alone	NULL
activates	NULL
these	NULL
kinases	NULL
)	NULL
.	NULL

After	NULL
15-20	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
11697	NULL
p38	NULL
kinase	NULL
p38	NULL
kinase	NULL
1	NULL
2	NULL
s	NULL
4	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
$	NULL
8	NULL
€	NULL
MBP	NULL
GST-ATF2	NULL
sg	NULL
:	NULL
0	NULL
H	NULL
«	NULL
is	NULL
;	NULL
£	NULL
-I	NULL
-	NULL
-	NULL
@	NULL
thoet	NULL
E9	NULL
p	NULL
&	NULL
o	NULL
P	NULL
8	NULL
n	NULL
?	NULL

i	NULL
.	NULL

IP	NULL
Q	NULL
ral	NULL
anti-CD3/28	NULL
-	NULL
+	NULL
3+	NULL
1	NULL
&	NULL
4	NULL
.	NULL

a/	NULL
-	NULL
%	NULL
Fog	NULL
w	NULL
&	NULL
a	NULL
8	NULL
E	NULL
&	NULL
40°	NULL
o	NULL
8a	NULL
£31	NULL
,	NULL
0	NULL
&	NULL
``	NULL
&	NULL
<	NULL
6	NULL
+	NULL
P	NULL
y	NULL
o	NULL
&	NULL
5	NULL
*	NULL
e	NULL
$	NULL
C	NULL
c-Jun	NULL
kinase	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
s	NULL
87-I	NULL
64-ez	NULL
«	NULL
4	NULL
GST-c-Jun-N	NULL
26-I	NULL
anti-HA-tag	NULL
22	NULL
:	NULL
tA	NULL
#	NULL
s	NULL
+	NULL
-l	NULL
<	NULL
«	NULL
4	NULL
Jnk2	NULL
33-	NULL
cus	NULL
ess	NULL
<	NULL
4	NULL
HCPTP	NULL
anti-CD3/28	NULL
4	NULL
+	NULL
|€	NULL
-	NULL
g	NULL
+|-	NULL
+	NULL
«	NULL
&	NULL
4§	NULL
‘	NULL
Z	NULL
«	NULL
q	NULL
``	NULL
;	NULL
c	NULL
}	NULL
q	NULL
<	NULL
q	NULL
&	NULL
dl\é°	NULL
salt	NULL
:	NULL
i235	NULL
]	NULL
;	NULL
x	NULL
“	NULL
Q9	NULL
Se	NULL
x'ﬁeé	NULL
}	NULL
5§	NULL
$	NULL
x	NULL
‘	NULL
b	NULL
$	NULL
+	NULL
BS	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
,	NULL
but	NULL
not	NULL
Junk	NULL
,	NULL
by	NULL
HePTP	NULL
.	NULL

a	NULL
,	NULL
phosphorylation	NULL
of	NULL
MBP	NULL
during	NULL
a	NULL
80-min	NULL
assay	NULL
by	NULL
10	NULL
ng	NULL
of	NULL
recombinant	NULL
p38	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
ng	NULL
of	NULL
GST-HePTP	NULL
,	NULL
GST	NULL
,	NULL
GST-HePTP-C2708	NULL
,	NULL
or	NULL
GST-SHP2	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type.b	NULL
,	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
with	NULL
GST-ATF2	NULL
as	NULL
a	NULL
substrate	NULL
of	NULL
HA-tagged	NULL
p38	NULL
kinase	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
anti-CDS8e	NULL
plus	NULL
anti-CD28	NULL
mAbs	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
autoradiogram	NULL
of	NULL
the	NULL
kinase	NULL
assay	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
p38	NULL
and	NULL
HePTP	NULL
was	NULL
visualized	NULL
by	NULL
anti-HA	NULL
tag	NULL
immunoblotting	NULL
(	NULL
fower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
in	NULL
another	NULL
independent	NULL
experiment	NULL
.	NULL

c	NULL
,	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
with	NULL
GST-c-Jun-N	NULL
as	NULL
a	NULL
substrate	NULL
of	NULL
HA-tagged	NULL
Jnk2	NULL
kinase	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
anti-CD8e	NULL
plus	NULL
anti-CD28	NULL
mAbs	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
autoradiogram	NULL
of	NULL
the	NULL
kinase	NULL
assay	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Jnk2	NULL
and	NULL
HePTP	NULL
was	NULL
visualized	NULL
by	NULL
anti-HA	NULL
tag	NULL
immunoblotting	NULL
(	NULL
Lower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
in	NULL
several	NULL
independent	NULL
experiments	NULL
.	NULL

the	NULL
tagged	NULL
kinases	NULL
were	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
their	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
GST-ATF2	NULL
or	NULL
GST-c-Jun-N	NULL
as	NULL
substrates	NULL
.	NULL

These	NULL
assays	NULL
revealed	NULL
that	NULL
HePTP	NULL
reduced	NULL
both	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
p38	NULL
and	NULL
its	NULL
further	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
but	NULL
not	NULL
the	NULL
activation	NULL
of	NULL
Jnk2	NULL
(	NULL
Fig	NULL
.	NULL

4c	NULL
)	NULL
.	NULL

The	NULL
cpm	NULL
in	NULL
the	NULL
GST-ATF2	NULL
band	NULL
were	NULL
reduced	NULL
in	NULL
lane	NULL
5	NULL
compared	NULL
with	NULL
lane	NULL
3	NULL
by	NULL
55	NULL
%	NULL
and	NULL
in	NULL
lane	NULL
6	NULL
compared	NULL
with	NULL
lane	NULL
4	NULL
by	NULL
78	NULL
%	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
p38	NULL
was	NULL
difficult	NULL
to	NULL
evaluate	NULL
due	NULL
the	NULL
similarity	NULL
in	NULL
size	NULL
with	NULL
HePTP	NULL
but	NULL
at	NULL
least	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
any	NULL
less	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
.	NULL

Jnk2	NULL
was	NULL
expressed	NULL
at	NULL
relatively	NULL
low	NULL
levels	NULL
but	NULL
equally	NULL
in	NULL
all	NULL
samples	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
HePTP	NULL
inhibits	NULL
p38	NULL
,	NULL
but	NULL
not	NULL
Jnk	NULL
,	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
Binding	NULL
Site	NULL
in	NULL
HePTP-The	NULL
region	NULL
of	NULL
HePTP	NULL
that	NULL
binds	NULL
Erk	NULL
and	NULL
p38	NULL
was	NULL
first	NULL
mapped	NULL
to	NULL
its	NULL
noncatalytic	NULL
N-terminal	NULL
92	NULL
amino	NULL
acids	NULL
.	NULL

A	NULL
GST	NULL
fusion	NULL
protein	NULL
of	NULL
HePTP	NULL
lacking	NULL
this	NULL
region	NULL
(	NULL
GST-AN	NULL
)	NULL
failed	NULL
to	NULL
bind	NULL
any	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-containing	NULL
proteins	NULL
,	NULL
Erk	NULL
,	NULL
or	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

50	NULL
)	NULL
in	NULL
lysates	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
containing	NULL
only	NULL
the	NULL
N-terminal	NULL
92	NULL
amino	NULL
acids	NULL
of	NULL
HePTP	NULL
(	NULL
GST-N	NULL
ter	NULL
)	NULL
bound	NULL
both	NULL
Erk	NULL
and	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

56	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
binding	NULL
region	NULL
more	NULL
precisely	NULL
,	NULL
we	NULL
made	NULL
three	NULL
smaller	NULL
constructs	NULL
encompassing	NULL
amino	NULL
acids	NULL
1-40	NULL
,	NULL
10-55	NULL
,	NULL
30-80	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
three	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
cell	NULL
lysates	NULL
,	NULL
washed	NULL
extensively	NULL
,	NULL
and	NULL
immunoblotted	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Erk	NULL
and	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
11698	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
a	NULL
b	NULL
C	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
MK	NULL
)	NULL
Anti-PTyr	NULL
Anti-PTyr	NULL
Anti-PTyr	NULL
for	NULL
Erk	NULL
and	NULL
p38	NULL
in	NULL
HePTP	NULL
.	NULL

a	NULL
,	NULL
anti-	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
(	NULL
anti-PTyr	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
anti-	NULL
64-	NULL
_	NULL
®	NULL
-	NULL
=	NULL
a	NULL
»	NULL
%	NULL
Erk2	NULL
(	NULL
second	NULL
panel	NULL
)	NULL
,	NULL
anti-p38	NULL
(	NULL
third	NULL
52-I	NULL
ap	NULL
-	NULL
fe	NULL
t	NULL
``	NULL
|	NULL
``	NULL
,	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
anti-GST	NULL
(	NULL
lowest	NULL
panel	NULL
)	NULL
39-7	NULL
«	NULL
te	NULL
a	NULL
»	NULL
immunoblot	NULL
of	NULL
material	NULL
bound	NULL
to	NULL
control	NULL
ge-GST	NULL
,	NULL
GST-HePTP	NULL
,	NULL
GST-HePTP-AN	NULL
,	NULL
21-	NULL
GST-HePTP-C2708	NULL
,	NULL
or	NULL
GST-HePTP-AN	NULL
:	NULL
Anti-erk2	NULL
Anti-Erk2	NULL
Anti-Erk2	NULL
C2708	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
in	NULL
lysates	NULL
of	NULL
un-	NULL
s2-	NULL
.	NULL

treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
39-	NULL
~es	NULL
e-	NULL
-|	NULL
<	NULL
Erk2	NULL
»	NULL
|	NULL
gigs	NULL
<	NULL
«	NULL
Erk2	NULL
»	NULL
100	NULL
uM	NULL
pervanadate	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
last	NULL
lane	NULL
is	NULL
cell	NULL
lysate	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

b	NULL
,	NULL
anti-	NULL
Anti-p38	NULL
Anti-p38	NULL
Anti-p38	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
anti-Erk2	NULL
(	NULL
middle	NULL
sa-panel	NULL
)	NULL
,	NULL
and	NULL
anti-p38	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
immu-	NULL
39-	NULL
-u	NULL
ame	NULL
«	NULL
«	NULL
«	NULL
«	NULL
p38	NULL
»	NULL
|	NULL
as	NULL
«	NULL
=	NULL
p38	NULL
»	NULL
|	NULL
-	NULL
exam	NULL
»	NULL
noblot	NULL
of	NULL
material	NULL
bound	NULL
to	NULL
control	NULL
GST-	NULL
e	NULL
vanadate	NULL
-	NULL
+	NULL
o	NULL
+	NULL
p	NULL
a	NULL
po	NULL
gs	NULL
ap	NULL
HePTP-N	NULL
ter	NULL
,	NULL
GST-HePTP-AN	NULL
,	NULL
or	NULL
GST-	NULL
Anti-GST	NULL
F=	NULL
a	NULL
ees	NULL
*	NULL
,	NULL
HePTP-N	NULL
ter-T45A/872A	NULL
in	NULL
a	NULL
similar	NULL
g	NULL
‘	NULL
z	NULL
‘	NULL
:	NULL
<	NULL
«	NULL
amep	NULL
34	NULL
“	NULL
if	NULL
9	NULL
;	NULL
6643	NULL
?	NULL

3	NULL
experiment	NULL
.	NULL

c	NULL
,	NULL
similar	NULL
experiment	NULL
with	NULL
39	NULL
-	NULL
wa	NULL
wae	NULL
sae	NULL
ith	NULL
-	NULL
,	NULL
46	NULL
“	NULL
£	NULL
41	NULL
ﬁ	NULL
&	NULL
43	NULL
the	NULL
shorter	NULL
N-terminal	NULL
constructs	NULL
,	NULL
GST-	NULL
e	NULL
‘	NULL
>	NULL
#	NULL
HePTP-N1	NULL
,	NULL
-N2	NULL
,	NULL
and	NULL
-N3	NULL
.	NULL

The	NULL
size	NULL
and	NULL
pmanaéte	NULL
2	NULL
g	NULL
``	NULL
C	NULL
o	NULL
Z	NULL
<	NULL
amount	NULL
of	NULL
the	NULL
GST	NULL
fusion	NULL
proteins	NULL
used	NULL
9	NULL
}	NULL
e	NULL
in	NULL
panels	NULL
b	NULL
and	NULL
c	NULL
were	NULL
verified	NULL
during	NULL
their	NULL
preparation	NULL
.	NULL

p38	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5¢	NULL
,	NULL
the	NULL
two	NULL
first	NULL
fragments	NULL
bound	NULL
both	NULL
Erk	NULL
and	NULL
p38	NULL
readily	NULL
,	NULL
whereas	NULL
the	NULL
third	NULL
did	NULL
not	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
binding	NULL
site	NULL
must	NULL
reside	NULL
within	NULL
amino	NULL
acids	NULL
10-30	NULL
,	NULL
perhaps	NULL
extending	NULL
into	NULL
the	NULL
30-40	NULL
region	NULL
,	NULL
which	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
binding	NULL
by	NULL
itself	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
by	NULL
MAP	NULL
Ki-nase-This	NULL
region	NULL
also	NULL
contains	NULL
two	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
for	NULL
a	NULL
proline-directed	NULL
kinase	NULL
(	NULL
such	NULL
as	NULL
Erk	NULL
)	NULL
,	NULL
Ser-72	NULL
,	NULL
and	NULL
Thr-45	NULL
.	NULL

Because	NULL
HePTP	NULL
was	NULL
readily	NULL
phosphorylated	NULL
on	NULL
both	NULL
serine	NULL
and	NULL
threonine	NULL
by	NULL
the	NULL
bound	NULL
Erk	NULL
and	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

36	NULL
)	NULL
and	NULL
by	NULL
recombinant	NULL
Erk2	NULL
(	NULL
Fig	NULL
.	NULL

6a	NULL
)	NULL
or	NULL
p38	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
mutated	NULL
these	NULL
residues	NULL
to	NULL
alanines	NULL
and	NULL
examined	NULL
their	NULL
phosphorylation	NULL
by	NULL
tryptic	NULL
peptide	NULL
mapping	NULL
,	NULL
which	NULL
revealed	NULL
that	NULL
both	NULL
peptides	NULL
containing	NULL
Ser	NULL
(	NULL
P	NULL
)	NULL
(	NULL
peptides	NULL
1	NULL
and	NULL
2	NULL
)	NULL
contained	NULL
Ser-72	NULL
,	NULL
whereas	NULL
Thr-45	NULL
was	NULL
the	NULL
phosphorylated	NULL
residue	NULL
in	NULL
peptides	NULL
3-5	NULL
(	NULL
Fig	NULL
.	NULL

6b	NULL
)	NULL
.	NULL

These	NULL
peptides	NULL
were	NULL
also	NULL
seen	NULL
in	NULL
tryptic	NULL
peptide	NULL
maps	NULL
of	NULL
HePTP	NULL
from	NULL
metabolically	NULL
°°P	NULL
;	NULL
-labeled	NULL
T	NULL
cells	NULL
but	NULL
were	NULL
missing	NULL
in	NULL
a	NULL
HePTP-T45A/S872A	NULL
mutant	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
noncatalytic	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
binds	NULL
Erk	NULL
and	NULL
p38	NULL
and	NULL
is	NULL
phosphorylated	NULL
at	NULL
Ser-72	NULL
and	NULL
Thr-45	NULL
by	NULL
these	NULL
kinases	NULL
.	NULL

Possible	NULL
Role	NULL
of	NULL
Phosphorylation	NULL
at	NULL
Thr-45	NULL
and	NULL
Ser-72-The	NULL
phosphorylation	NULL
of	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
by	NULL
the	NULL
Erk	NULL
or	NULL
p38	NULL
kinases	NULL
introduces	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
regulatory	NULL
role	NULL
of	NULL
this	NULL
event	NULL
.	NULL

Measurement	NULL
of	NULL
the	NULL
catalytic	NULL
activity	NULL
of	NULL
HePTP	NULL
revealed	NULL
a	NULL
small	NULL
decrease	NULL
in	NULL
activity	NULL
upon	NULL
phosphorylation	NULL
by	NULL
Erk	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
decrease	NULL
is	NULL
presently	NULL
of	NULL
questionable	NULL
significance	NULL
.	NULL

Instead	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
possibility	NULL
that	NULL
phosphorylation	NULL
regulates	NULL
the	NULL
physical	NULL
association	NULL
between	NULL
HePTP	NULL
and	NULL
Erk	NULL
or	NULL
p38	NULL
.	NULL

Because	NULL
a	NULL
GST-N	NULL
ter	NULL
protein	NULL
having	NULL
both	NULL
the	NULL
T45A	NULL
and	NULL
ST7T2A	NULL
mutations	NULL
still	NULL
bound	NULL
Erk	NULL
and	NULL
p38	NULL
as	NULL
readily	NULL
as	NULL
the	NULL
wild-type	NULL
GST-N	NULL
ter	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

56	NULL
)	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
the	NULL
hydroxyl	NULL
groups	NULL
of	NULL
Thr-45	NULL
and	NULL
Ser-72	NULL
or	NULL
their	NULL
phosphorylation	NULL
are	NULL
not	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
Erk	NULL
or	NULL
p38	NULL
.	NULL

To	NULL
test	NULL
the	NULL
opposite	NULL
,	NULL
namely	NULL
that	NULL
phosphorylation	NULL
is	NULL
involved	NULL
in	NULL
dissociation	NULL
of	NULL
the	NULL
kinases	NULL
,	NULL
we	NULL
incubated	NULL
HePTP-Erk	NULL
complexes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATP	NULL
and	NULL
Mg**	NULL
at	NULL
37°C	NULL
and	NULL
measured	NULL
the	NULL
release	NULL
of	NULL
HePTP	NULL
.	NULL

These	NULL
experiments	NULL
utilized	NULL
catalytically	NULL
active	NULL
GST-Erk2	NULL
adsorbed	NULL
onto	NULL
glutathione-Sepharose	NULL
with	NULL
bound	NULL
HA-tagged	NULL
HePTP-C2708	NULL
from	NULL
transfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
dissociation	NULL
of	NULL
HePTP	NULL
from	NULL
the	NULL
beads	NULL
(	NULL
Fig	NULL
.	NULL

6c	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
binds	NULL
Erk	NULL
and	NULL
p38	NULL
but	NULL
may	NULL
release	NULL
them	NULL
upon	NULL
phosphorylation	NULL
.	NULL

Curiously	NULL
,	NULL
both	NULL
phosphorylation	NULL
sites	NULL
are	NULL
outside	NULL
the	NULL
minimal	NULL
necessary	NULL
binding	NULL
site	NULL
for	NULL
Erk	NULL
and	NULL
p38	NULL
,	NULL
but	NULL
their	NULL
phosphorylation	NULL
could	NULL
influence	NULL
the	NULL
4	NULL
&	NULL
ffff	NULL
conformation	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
.	NULL

Elimination	NULL
of	NULL
the	NULL
Phosphorylation	NULL
Sites	NULL
Augments	NULL
Inhibition	NULL
of	NULL
MAP	NULL
Kinase	NULL
by	NULL
HePTP-To	NULL
study	NULL
the	NULL
impact	NULL
of	NULL
phosphorylation	NULL
of	NULL
HePTP	NULL
at	NULL
Thr-45	NULL
and	NULL
Ser-72	NULL
in	NULL
intact	NULL
cells	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
mutant	NULL
in	NULL
which	NULL
both	NULL
residues	NULL
were	NULL
replaced	NULL
by	NULL
alanine	NULL
residues	NULL
.	NULL

The	NULL
mutant	NULL
,	NULL
HePTP-T45A/872A	NULL
,	NULL
was	NULL
included	NULL
in	NULL
a	NULL
co-transfection	NULL
experiment	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
Fig	NULL
.	NULL

1f	NULL
using	NULL
JCaM1	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6d	NULL
,	NULL
wild-type	NULL
HePTP	NULL
reduced	NULL
the	NULL
anti-CD3-induced	NULL
activity	NULL
of	NULL
Erk2	NULL
to	NULL
about	NULL
half	NULL
,	NULL
whereas	NULL
HePTP-C27058	NULL
augmented	NULL
it	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
HePTP-T45A/ST72A	NULL
was	NULL
more	NULL
efficient	NULL
than	NULL
wild-type	NULL
HePTP	NULL
and	NULL
essentially	NULL
eliminated	NULL
any	NULL
increase	NULL
in	NULL
MAP	NULL
kinase	NULL
activation	NULL
in	NULL
the	NULL
anti-CD3	NULL
stimulated	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
phosphorylation	NULL
of	NULL
HePTP	NULL
at	NULL
Thr-45	NULL
and/or	NULL
Ser-72	NULL
is	NULL
not	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
MAP	NULL
kinase	NULL
.	NULL

Rather	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
phosphorylation	NULL
has	NULL
the	NULL
opposite	NULL
effect	NULL
,	NULL
namely	NULL
to	NULL
lessen	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
HePTP	NULL
.	NULL

This	NULL
fits	NULL
our	NULL
hypothesis	NULL
that	NULL
phosphorylation	NULL
causes	NULL
a	NULL
dissociation	NULL
of	NULL
Erk	NULL
from	NULL
HePTP	NULL
;	NULL
the	NULL
T45A/S72A	NULL
mutant	NULL
would	NULL
not	NULL
allow	NULL
bound	NULL
Erk	NULL
to	NULL
escape	NULL
,	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
Erk	NULL
activation	NULL
would	NULL
be	NULL
stronger	NULL
.	NULL

DISCUSSION	NULL
Taken	NULL
together	NULL
,	NULL
our	NULL
findings	NULL
show	NULL
that	NULL
HePTP	NULL
,	NULL
a	NULL
strictly	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-specific	NULL
protein	NULL
phosphatase	NULL
,	NULL
forms	NULL
a	NULL
physical	NULL
complex	NULL
through	NULL
a	NULL
small	NULL
region	NULL
in	NULL
its	NULL
unique	NULL
N	NULL
terminus	NULL
with	NULL
the	NULL
Erk	NULL
and	NULL
p38	NULL
MAP	NULL
kinases	NULL
.	NULL

Because	NULL
HePTP	NULL
very	NULL
efficiently	NULL
dephosphorylates	NULL
these	NULL
kinases	NULL
and	NULL
inactivates	NULL
them	NULL
in	NULL
vitro	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
the	NULL
physical	NULL
association	NULL
serves	NULL
to	NULL
position	NULL
HePTP	NULL
correctly	NULL
for	NULL
this	NULL
catalysis	NULL
.	NULL

The	NULL
small	NULL
amount	NULL
of	NULL
HePTP	NULL
required	NULL
for	NULL
MAP	NULL
kinase	NULL
inactivation	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
reduction	NULL
in	NULL
Erk	NULL
phosphorylation	NULL
and	NULL
activity	NULL
in	NULL
intact	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
HePTP	NULL
indicate	NULL
that	NULL
this	NULL
function	NULL
of	NULL
HePTP	NULL
is	NULL
physiologically	NULL
significant	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
HePTP	NULL
is	NULL
readily	NULL
phosphorylated	NULL
by	NULL
Erk	NULL
and	NULL
p38	NULL
at	NULL
Thr-45	NULL
and	NULL
Ser-72	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
phosphorylated	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
very	NULL
similar	NULL
conclusions	NULL
were	NULL
recently	NULL
drawn	NULL
using	NULL
mast	NULL
cells	NULL
from	NULL
mice	NULL
deficient	NULL
in	NULL
HePTP	NULL
.	NULL
``	NULL

Together	NULL
these	NULL
observations	NULL
indicate	NULL
that	NULL
the	NULL
role	NULL
of	NULL
HePTP	NULL
is	NULL
to	NULL
negatively	NULL
regulate	NULL
the	NULL
Erk	NULL
and	NULL
p38	NULL
MAP	NULL
kinases	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Whether	NULL
the	NULL
related	NULL
PTPases	NULL
STEP	NULL
and	NULL
PCPTP1	NULL
carry	NULL
out	NULL
this	NULL
task	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Both	NULL
share	NULL
an	NULL
N-terminal	NULL
sequence	NULL
with	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
to	NULL
the	NULL
®	NULL
B.	NULL
Zanke	NULL
,	NULL
personal	NULL
communication	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
a	NULL
kinase	NULL
tryptic	NULL
peptide	NULL
map	NULL
PAA	NULL
1	NULL
2	NULL
2	NULL
y	NULL
peptide	NULL
1	NULL
peptide	NULL
2	NULL
e	NULL
ﬂ	NULL
f	NULL
P5	NULL
“	NULL
.	NULL

ppp	NULL
,	NULL
|PSer_	NULL
,	NULL
,	NULL
Eth	NULL
g	NULL
4	NULL
t.	NULL
}	NULL
PTyr	NULL
PTyr	NULL
e	NULL
'	NULL
peptide	NULL
4____	NULL
peptide	NULL
5	NULL
PSer__	NULL
f	NULL
PSeIr	NULL
``	NULL
A	NULL
z	NULL
.	NULL

1	NULL
{	NULL
Th	NULL
“	NULL
rim	NULL
f	NULL
d	NULL
PTyr	NULL
PTyr	NULL
origin	NULL
b	NULL
wt	NULL
HePTP	NULL
___	NULL
HePTP-S72A	NULL
_	NULL
HePTP-T45A	NULL
5	NULL
4	NULL
4	NULL
;	NULL
#	NULL
2	NULL
.	NULL

1	NULL
é.	NULL
i	NULL
+	NULL
``	NULL
$	NULL
M	NULL
‘	NULL
(	NULL
Eigin	NULL
039m	NULL
aggin	NULL
c	NULL
d	NULL
-	NULL
MAP	NULL
kinase	NULL
soluble	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
s	NULL
9	NULL
10	NULL
«	NULL
«	NULL
-	NULL
m	NULL
»	NULL
amm|	NULL
<	NULL
HePTP-C2705	NULL
bound	NULL
aap	NULL
aa	NULL
»	NULL
«	NULL
|	NULL
<	NULL
4	NULL
HcPTP-C2705S	NULL
sa-0	NULL
:	NULL
2	NULL
,	NULL
5	NULL
!	NULL

23	NULL
:	NULL
29-anti-CD3	NULL
X46	NULL
,	NULL
&	NULL
<	NULL
(	NULL
t-	NULL
&	NULL
#	NULL
<	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Mapping	NULL
of	NULL
phosphorylation	NULL
sites	NULL
in	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
.	NULL

a	NULL
,	NULL
first	NULL
panel	NULL
,	NULL
autoradiogram	NULL
of	NULL
GST-HePTP-C2708	NULL
incubated	NULL
with	NULL
a	NULL
lysate	NULL
from	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
pervanadate-treated	NULL
cells	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
washed	NULL
extensively	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Second	NULL
panel	NULL
,	NULL
tryptic	NULL
peptide	NULL
map	NULL
of	NULL
the	NULL
band	NULL
in	NULL
lane	NULL
2	NULL
of	NULL
the	NULL
first	NULL
panel	NULL
.	NULL

Third	NULL
panel	NULL
,	NULL
phosphoamino	NULL
acid	NULL
analysis	NULL
(	NULL
PAA	NULL
)	NULL
of	NULL
peptides	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
from	NULL
the	NULL
same	NULL
tryptic	NULL
peptide	NULL
map	NULL
.	NULL

PSer	NULL
,	NULL
Ser	NULL
(	NULL
P	NULL
)	NULL
;	NULL
PTyr	NULL
,	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
.	NULL

b	NULL
,	NULL
tryptic	NULL
peptide	NULL
maps	NULL
of	NULL
GST-HePTP	NULL
,	NULL
GST-HePTP-872A	NULL
,	NULL
and	NULL
GST-HePTP-T45A	NULL
phosphorylated	NULL
by	NULL
recombinant	NULL
Erk2	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
.	NULL

wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

c	NULL
,	NULL
anti-HA	NULL
immunoblots	NULL
of	NULL
superna-tants	NULL
(	NULL
upper	NULL
panel	NULL
;	NULL
soluble	NULL
)	NULL
or	NULL
pellets	NULL
(	NULL
lower	NULL
panel	NULL
;	NULL
bound	NULL
)	NULL
of	NULL
glutathione-Sepharose	NULL
beads	NULL
preadsorbed	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
active	NULL
GST-Erk2	NULL
incubated	NULL
in	NULL
a	NULL
lysate	NULL
of	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
HA-tagged	NULL
HePTP-C2708	NULL
,	NULL
washed	NULL
extensively	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
10	NULL
uM	NULL
ATP	NULL
at	NULL
87	NULL
°C	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Note	NULL
the	NULL
increase	NULL
in	NULL
soluble	NULL
HePTP	NULL
and	NULL
the	NULL
decrease	NULL
in	NULL
bound	NULL
HePTP	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
one	NULL
other	NULL
experiment	NULL
for	NULL
each	NULL
panel	NULL
.	NULL

d	NULL
,	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
of	NULL
myc-tagged	NULL
Erk2	NULL
MAP	NULL
kinase	NULL
expressed	NULL
in	NULL
JCaM1	NULL
cells	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
anti-CD8e	NULL
mAbs	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
autoradiogram	NULL
of	NULL
the	NULL
kinase	NULL
assay	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
Erk2	NULL
in	NULL
the	NULL
precipitates	NULL
was	NULL
visualized	NULL
by	NULL
immunoblotting	NULL
(	NULL
second	NULL
panel	NULL
)	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
HePTP	NULL
by	NULL
anti-HA	NULL
tag	NULL
immunoblotting	NULL
of	NULL
the	NULL
lysates	NULL
(	NULL
third	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
in	NULL
another	NULL
independent	NULL
experiment	NULL
.	NULL

Erk/p38	NULL
binding	NULL
region	NULL
of	NULL
HePTP	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
MAP	NULL
kinases	NULL
are	NULL
the	NULL
targets	NULL
for	NULL
dual-specificity	NULL
phosphatases	NULL
(	NULL
35-37	NULL
)	NULL
in	NULL
T	NULL
cells	NULL
;	NULL
particularly	NULL
,	NULL
the	NULL
Pacl	NULL
phosphatase	NULL
(	NULL
86	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
HePTP	NULL
(	NULL
4	NULL
,	NULL
6	NULL
)	NULL
,	NULL
however	NULL
,	NULL
these	NULL
enzymes	NULL
are	NULL
not	NULL
present	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
but	NULL
are	NULL
11699	NULL
PTKs	NULL
}	NULL
-	NULL
SHP1	NULL
$	NULL
35	NULL
Ras	NULL
cytoplasm	NULL
a	NULL
Raf	NULL
t	NULL
Mfk	NULL
-2	NULL
_	NULL
Erkt-	NULL
Paci	NULL
/	NULL
\/	NULL
nucleus	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Proposed	NULL
sequential	NULL
phosphatase	NULL
model	NULL
of	NULL
Erk	NULL
regula-tion	NULL
.	NULL

TCR	NULL
,	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Arrows	NULL
refer	NULL
to	NULL
stimulation	NULL
,	NULL
and	NULL
T-shaped	NULL
lines	NULL
refer	NULL
to	NULL
inhibition	NULL
.	NULL

PTKs	NULL
,	NULL
protein-tyrosine	NULL
kinases	NULL
.	NULL

induced	NULL
and	NULL
synthesized	NULL
some	NULL
30-60	NULL
min	NULL
after	NULL
receptor	NULL
liga-tion	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
they	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
suppression	NULL
of	NULL
MAP	NULL
kinases	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
or	NULL
during	NULL
early	NULL
time	NULL
points	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
also	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
that	NULL
the	NULL
inactivation	NULL
of	NULL
MAP	NULL
kinases	NULL
precedes	NULL
the	NULL
induction	NULL
of	NULL
dual-specificity	NULL
phosphatases	NULL
and	NULL
that	NULL
a	NULL
cytosolic	NULL
PTP	NULL
ase	NULL
is	NULL
involved	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
the	NULL
budding	NULL
yeast	NULL
,	NULL
Saccha-romyces	NULL
cerevisiae	NULL
,	NULL
the	NULL
mating	NULL
pheromone-induced	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
Fus3p	NULL
and	NULL
Kss1p	NULL
is	NULL
tightly	NULL
regulated	NULL
by	NULL
the	NULL
concerted	NULL
action	NULL
of	NULL
the	NULL
dual-specificity	NULL
protein	NULL
phosphatase	NULL
Msg5p	NULL
and	NULL
the	NULL
conventional	NULL
PTPases	NULL
Ptp2p	NULL
and	NULL
Ptp3p	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
this	NULL
system	NULL
,	NULL
the	NULL
latter	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
basal	NULL
suppression	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
and	NULL
for	NULL
terminating	NULL
their	NULL
ligand-induced	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
dual-specificity	NULL
phosphatase	NULL
is	NULL
encoded	NULL
by	NULL
an	NULL
inducible	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
role	NULL
of	NULL
the	NULL
enzyme	NULL
is	NULL
primarily	NULL
to	NULL
dephosphorylate	NULL
the	NULL
MAP	NULL
kinases	NULL
at	NULL
later	NULL
time	NULL
points	NULL
(	NULL
``	NULL
recovery	NULL
``	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
a	NULL
mammalian	NULL
PTPase	NULL
,	NULL
HePTP	NULL
,	NULL
is	NULL
a	NULL
functional	NULL
homologue	NULL
of	NULL
Ptp2p	NULL
and	NULL
Ptp3p	NULL
and	NULL
is	NULL
responsible	NULL
for	NULL
basal	NULL
dephosphorylation	NULL
and	NULL
control	NULL
at	NULL
early	NULL
time	NULL
points	NULL
.	NULL

Lymphocyte	NULL
activation	NULL
is	NULL
initiated	NULL
by	NULL
the	NULL
action	NULL
of	NULL
several	NULL
protein-tyrosine	NULL
kinases	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
and	NULL
is	NULL
very	NULL
likely	NULL
to	NULL
be	NULL
negatively	NULL
regulated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
PTPases	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Only	NULL
one	NULL
such	NULL
PTPase	NULL
is	NULL
currently	NULL
known	NULL
,	NULL
namely	NULL
SHPI1	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
which	NULL
dephosphorylates	NULL
receptor-associated	NULL
signaling	NULL
molecules	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
HePTP	NULL
functions	NULL
at	NULL
a	NULL
distinct	NULL
step	NULL
to	NULL
negatively	NULL
regulate	NULL
lymphocyte	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
SHP1	NULL
,	NULL
HePTP	NULL
has	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
specificity	NULL
for	NULL
Erk	NULL
and	NULL
perhaps	NULL
p38	NULL
MAP	NULL
kinases	NULL
and	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
upstream	NULL
of	NULL
these	NULL
kinases	NULL
.	NULL

This	NULL
specificity	NULL
is	NULL
due	NULL
,	NULL
in	NULL
part	NULL
,	NULL
to	NULL
a	NULL
strong	NULL
physical	NULL
association	NULL
of	NULL
HePTP	NULL
with	NULL
Erk	NULL
and	NULL
p38	NULL
,	NULL
an	NULL
interaction	NULL
that	NULL
is	NULL
constitutive	NULL
and	NULL
occurs	NULL
through	NULL
the	NULL
unphos-phorylated	NULL
N	NULL
terminus	NULL
of	NULL
HePTP	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
upon	NULL
activation	NULL
of	NULL
Erk	NULL
by	NULL
Mek	NULL
,	NULL
the	NULL
activated	NULL
Erk	NULL
either	NULL
rapidly	NULL
phosphorylates	NULL
Thr-45	NULL
and	NULL
Ser-72	NULL
,	NULL
dissociates	NULL
(	NULL
perhaps	NULL
also	NULL
because	NULL
of	NULL
other	NULL
mechanisms	NULL
)	NULL
,	NULL
and	NULL
escapes	NULL
into	NULL
the	NULL
nucleus	NULL
to	NULL
phosphorylate	NULL
its	NULL
nuclear	NULL
substrates	NULL
.	NULL

A	NULL
fraction	NULL
of	NULL
the	NULL
activated	NULL
Erk	NULL
molecules	NULL
,	NULL
however	NULL
,	NULL
are	NULL
rapidly	NULL
inactivated	NULL
by	NULL
the	NULL
bound	NULL
HePTP	NULL
.	NULL

As	NULL
determined	NULL
by	NULL
immunofluorescence	NULL
,	NULL
HePTP	NULL
appears	NULL
to	NULL
remain	NULL
exclusively	NULL
cytosolic	NULL
(	NULL
Ref	NULL
.	NULL

10	NULL
)	NULL
``	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
unable	NULL
to	NULL
inactivate	NULL
MAP	NULL
kinase	NULL
molecules	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Instead	NULL
,	NULL
these	NULL
are	NULL
later	NULL
inactivated	NULL
by	NULL
the	NULL
nuclear	NULL
dual-specificity	NULL
phosphatases	NULL
,	NULL
which	NULL
are	NULL
absent	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
but	NULL
are	NULL
induced	NULL
within	NULL
30-60	NULL
min	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

This	NULL
sequential	NULL
phosphatase	NULL
model	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
provides	NULL
a	NULL
flexible	NULL
mechanism	NULL
for	NULL
the	NULL
regulation	NULL
and	NULL
fine-tuning	NULL
of	NULL
MAP	NULL
kinases	NULL
,	NULL
which	NULL
function	NULL
as	NULL
crucial	NULL
signal	NULL
integration	NULL
and	NULL
decision	NULL
points	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
in	NULL
growth	NULL
and	NULL
stress	NULL
responses	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

Our	NULL
model	NULL
predicts	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
HePTP	NULL
in	NULL
positive	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
46	NULL
)	NULL
,	NULL
cytokine	NULL
pro	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
11700	NULL
HePTP	NULL
Binds	NULL
and	NULL
Dephosphorylates	NULL
MAP	NULL
Kinase	NULL
duction	NULL
(	NULL
27	NULL
,	NULL
47	NULL
)	NULL
,	NULL
T	NULL
cell	NULL
proliferation	NULL
(	NULL
48	NULL
)	NULL
,	NULL
or	NULL
anergy	NULL
(	NULL
49	NULL
)	NULL
and	NULL
potentially	NULL
in	NULL
other	NULL
MAP	NULL
kinase-dependent	NULL
aspects	NULL
of	NULL
T	NULL
cell	NULL
differentiation	NULL
and	NULL
activation	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Brent	NULL
Zanke	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
HePTP	NULL
cDNA	NULL
and	NULL
for	NULL
valuable	NULL
discussions	NULL
,	NULL
to	NULL
Toshi	NULL
Kawakami	NULL
and	NULL
Bob	NULL
Abraham	NULL
for	NULL
reagents	NULL
,	NULL
and	NULL
to	NULL
Drs	NULL
.	NULL

Carl	NULL
Ware	NULL
and	NULL
Douglas	NULL
Green	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sefton	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

77	NULL
,	NULL
1311-1315	NULL
2	NULL
.	NULL

Cantley	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Auger	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Carpenter	NULL
,	NULL
C.	NULL
,	NULL
Duckworth	NULL
,	NULL
B.	NULL
,	NULL
Graziani	NULL
,	NULL
A.	NULL
,	NULL
Kapeller	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Soltoff	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
281-302	NULL
3	NULL
.	NULL

Bishop	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
235-248	NULL
4	NULL
.	NULL

Zanke	NULL
,	NULL
B.	NULL
,	NULL
Suzuki	NULL
,	NULL
H.	NULL
,	NULL
Kishihara	NULL
,	NULL
K.	NULL
,	NULL
Mizzen	NULL
,	NULL
L.	NULL
,	NULL
Minden	NULL
,	NULL
M.	NULL
,	NULL
Pawson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Mak	NULL
,	NULL
T.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22	NULL
,	NULL
285-239	NULL
5	NULL
.	NULL

Adachi	NULL
,	NULL
M.	NULL
,	NULL
Sekiya	NULL
,	NULL
M.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Kumura	NULL
,	NULL
Y.	NULL
,	NULL
Ogita	NULL
,	NULL
Z.-L.	NULL
,	NULL
Hinoda	NULL
,	NULL
Y.	NULL
,	NULL
Imai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yachi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

186	NULL
,	NULL
1607-1615	NULL
6	NULL
.	NULL

Saxena	NULL
,	NULL
M.	NULL
,	NULL
Williams	NULL
,	NULL
S.	NULL
,	NULL
Gilman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
15340-15344	NULL
7	NULL
.	NULL

Lombroso	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Murdoch	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Lerner	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7242-7246	NULL
8	NULL
.	NULL

Shiozuka	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
Y.	NULL
,	NULL
Ikeda	NULL
,	NULL
T.	NULL
,	NULL
Hashimoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kawashima	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Gene	NULL
162	NULL
,	NULL
279-284	NULL
9	NULL
.	NULL

Sharma	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Lombroso	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
49-53	NULL
10	NULL
.	NULL

Sweiter	NULL
,	NULL
M.	NULL
,	NULL
Berenstein	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Swaim	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
and	NULL
Siraganian	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
21902-21906	NULL
11	NULL
.	NULL

Zanke	NULL
,	NULL
B.	NULL
,	NULL
Squire	NULL
,	NULL
J.	NULL
,	NULL
Griesser	NULL
,	NULL
H.	NULL
,	NULL
Henry	NULL
,	NULL
M.	NULL
,	NULL
Suzuki	NULL
,	NULL
H.	NULL
,	NULL
Patterson	NULL
,	NULL
B.	NULL
,	NULL
Minden	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mak	NULL
,	NULL
T.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Leukemia	NULL
(	NULL
Baltimore	NULL
)	NULL
8	NULL
,	NULL
236-244	NULL
12	NULL
.	NULL

Fonatsch	NULL
,	NULL
C.	NULL
,	NULL
Haase	NULL
,	NULL
D.	NULL
,	NULL
Freund	NULL
,	NULL
M.	NULL
,	NULL
Bartels	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tesch	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

56	NULL
,	NULL
243-253	NULL
13	NULL
.	NULL

Mamaev	NULL
,	NULL
N.	NULL
,	NULL
Mamaeva	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Pavlova	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Patterson	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

85	NULL
,	NULL
21-25	NULL
14	NULL
.	NULL

Mitelman	NULL
,	NULL
F.	NULL
,	NULL
Kaneko	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Trent	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cytogenet	NULL
.	NULL

Cell	NULL
Genet	NULL
.	NULL

58	NULL
,	NULL
1503-1579	NULL
15	NULL
.	NULL

Adachi	NULL
,	NULL
M.	NULL
,	NULL
Sekiya	NULL
,	NULL
M.	NULL
,	NULL
Ishino	NULL
,	NULL
M.	NULL
,	NULL
Sasaki	NULL
,	NULL
H.	NULL
,	NULL
Hinoda	NULL
,	NULL
Y.	NULL
,	NULL
Imai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yachi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

838	NULL
,	NULL
47-52	NULL
16	NULL
.	NULL

Hata	NULL
,	NULL
D.	NULL
,	NULL
Kitaura	NULL
,	NULL
J.	NULL
,	NULL
Hartman	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Kawakami	NULL
,	NULL
Y.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kawakami	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
10979-10987	NULL
17	NULL
.	NULL

Straus	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
585-593	NULL
18	NULL
.	NULL

Williams	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Schreiber	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Zhang	NULL
,	NULL
W.	NULL
,	NULL
Wange	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Leibson	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1388-1399	NULL
19	NULL
.	NULL

Jascur	NULL
,	NULL
T.	NULL
,	NULL
Gilman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
14483-14488	NULL
20	NULL
.	NULL

Williams	NULL
,	NULL
S.	NULL
,	NULL
Couture	NULL
,	NULL
C.	NULL
,	NULL
Gilman	NULL
,	NULL
J.	NULL
,	NULL
Jascur	NULL
,	NULL
T.	NULL
,	NULL
Deckert	NULL
,	NULL
M.	NULL
,	NULL
Altman	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

245	NULL
,	NULL
84-90	NULL
Luo	NULL
,	NULL
K.	NULL
,	NULL
Hurley	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Sefton	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Oncogene	NULL
5	NULL
,	NULL
921-928	NULL
Altman	NULL
,	NULL
A.	NULL
,	NULL
Coggeshall	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

48	NULL
,	NULL
227-360	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Lob	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
388-8342	NULL
Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Sun	NULL
,	NULL
Y.-L.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Hoey	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
6299-6310	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15	NULL
,	NULL
707-747	NULL
Foletta	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Segal	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

63	NULL
,	NULL
139-152	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16483-16486	NULL
Whitehurst	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
Geppert	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
1020-1029	NULL
Zheng	NULL
,	NULL
C.-F.	NULL
,	NULL
and	NULL
Guan	NULL
,	NULL
K.-L.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1123-1131	NULL
Whitmarsh	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Shore	NULL
,	NULL
P.	NULL
,	NULL
Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
403-407	NULL
Siegel	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
18472-18477	NULL
Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
Bowden	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
401-406	NULL
Couture	NULL
,	NULL
C.	NULL
,	NULL
Songyang	NULL
,	NULL
Z.	NULL
,	NULL
Jascur	NULL
,	NULL
T.	NULL
,	NULL
Williams	NULL
,	NULL
S.	NULL
,	NULL
Tailor	NULL
,	NULL
P.	NULL
,	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
and	NULL
Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
24880-24884	NULL
Zhang	NULL
,	NULL
W.	NULL
,	NULL
Sloan-Lancaster	NULL
,	NULL
J.	NULL
,	NULL
Kitchen	NULL
,	NULL
J.	NULL
,	NULL
Trible	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
92	NULL
,	NULL
83-92	NULL
Keyse	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Emslie	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
859	NULL
,	NULL
644-647	NULL
Rohan	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
P.	NULL
,	NULL
Moskaluk	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Kearns	NULL
,	NULL
M.	NULL
,	NULL
Krutzsch	NULL
,	NULL
H.	NULL
,	NULL
Siewbenlist	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Kelly	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1763-1766	NULL
Keyse	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Semin	NULL
.	NULL

Cell	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
148-152	NULL
Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Gomez	NULL
,	NULL
N.	NULL
,	NULL
Moorhead	NULL
,	NULL
G.	NULL
,	NULL
Lewis	NULL
,	NULL
T.	NULL
,	NULL
Keyse	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
283-295	NULL
Gopalbhai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Meloche	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

174	NULL
,	NULL
35-47	NULL
Zhan	NULL
,	NULL
X.-L.	NULL
,	NULL
Deschenes	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Guan	NULL
,	NULL
K.-L.	NULL
(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
1690-1702	NULL
Mustelin	NULL
,	NULL
T.	NULL
,	NULL
Coggeshall	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Isakov	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1584-1587	NULL
Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
351-856	NULL
Mustelin	NULL
,	NULL
T.	NULL
,	NULL
Brockdorff	NULL
,	NULL
J.	NULL
,	NULL
Gjérloff-Wingren	NULL
,	NULL
A.	NULL
,	NULL
Tailor	NULL
,	NULL
P.	NULL
,	NULL
Han	NULL
,	NULL
S.	NULL
,	NULL
Wang	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Saxena	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Front	NULL
.	NULL

Biosci	NULL
.	NULL

8	NULL
,	NULL
1066-1096	NULL
D'Ambrosio	NULL
,	NULL
D.	NULL
,	NULL
Hippen	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Minskoff	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Mellman	NULL
,	NULL
L	NULL
,	NULL
Pani	NULL
,	NULL
G.	NULL
,	NULL
Siminovitch	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Cambier	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
298-296	NULL
Pani	NULL
,	NULL
G.	NULL
,	NULL
Fischer	NULL
,	NULL
K.-D.	NULL
Mlinaric-Rascan	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Siminovitch	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
839-852	NULL
Alberola-lla	NULL
,	NULL
J.	NULL
,	NULL
Forbush	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Seger	NULL
,	NULL
R.	NULL
,	NULL
Krebs	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
878	NULL
,	NULL
620-623	NULL
Egerton	NULL
,	NULL
M.	NULL
,	NULL
Fitzpatrick	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Catling	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Kelso	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26	NULL
,	NULL
2279-2285	NULL
DeSilva	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Jones	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Favata	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Jaffee	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
Magolda	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Trzaskos	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Scerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
4175-4181	NULL
Li	NULL
,	NULL
W.	NULL
,	NULL
Whaley	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Mondino	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Mueller	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
271	NULL
,	NULL
1272-1276	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Inhibition	NULL
of	NULL
T	NULL
Cell	NULL
Signaling	NULL
by	NULL
Mitogen-activated	NULL
Protein	NULL
Kinase-targeted	NULL
Hematopoietic	NULL
Tyrosine	NULL
Phosphatase	NULL
(	NULL
HePTP	NULL
)	NULL
Manju	NULL
Saxena	NULL
,	NULL
Scott	NULL
Williams	NULL
,	NULL
Johannes	NULL
Brockdorff	NULL
,	NULL
Jennifer	NULL
Gilman	NULL
and	NULL
Tomas	NULL
Mustelin	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:11693-11700.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.17.11693	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/17/11693	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
references	NULL
,	NULL
22	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
7/1	NULL
1693.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

